10-Q
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
|
|
|
þ |
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2005
or
|
|
|
o |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number: 1-16095
Aetna Inc.
(Exact name of registrant as specified in its charter)
|
|
|
Pennsylvania
|
|
23-2229683 |
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.) |
|
|
|
151 Farmington Avenue, Hartford, CT
|
|
06156 |
(Address of principal executive offices)
|
|
(Zip Code) |
|
|
|
Registrants telephone number, including area code
|
|
(860) 273-0123 |
|
|
|
Former name, former address and former fiscal year, if changed since last report: N/A |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for
such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. þ Yes ¨ No
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). þ Yes ¨ No
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ¨ Yes þ No
There were 286,010,804 shares of voting common stock with a par value of $.01 outstanding at
September 30, 2005.
Part I Financial Information
Item 1. Financial Statements
Consolidated Statements of Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months |
|
|
For the Nine Months |
|
|
Ended September 30, |
|
|
Ended September 30, |
(Millions, except per common share data) |
|
2005 |
|
|
2004 |
|
|
2005 |
|
|
2004 |
|
|
Revenue: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Health care premiums |
|
$ |
4,291.3 |
|
|
$ |
3,786.6 |
|
|
$ |
12,490.5 |
|
|
$ |
10,992.4 |
|
Other premiums |
|
|
494.2 |
|
|
|
463.5 |
|
|
|
1,494.4 |
|
|
|
1,340.6 |
|
Administrative services contract fees |
|
|
583.1 |
|
|
|
507.1 |
|
|
|
1,724.4 |
|
|
|
1,536.5 |
|
Net investment income |
|
|
279.9 |
|
|
|
253.9 |
|
|
|
827.7 |
|
|
|
785.6 |
|
Other revenue * |
|
|
43.7 |
|
|
|
8.8 |
|
|
|
68.9 |
|
|
|
29.2 |
|
Net realized capital gains |
|
|
8.5 |
|
|
|
19.6 |
|
|
|
18.6 |
|
|
|
51.5 |
|
|
Total revenue |
|
|
5,700.7 |
|
|
|
5,039.5 |
|
|
|
16,624.5 |
|
|
|
14,735.8 |
|
|
Benefits and expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Health care costs ** |
|
|
3,390.4 |
|
|
|
2,994.3 |
|
|
|
9,683.6 |
|
|
|
8,611.2 |
|
Current and future benefits |
|
|
581.8 |
|
|
|
548.6 |
|
|
|
1,778.4 |
|
|
|
1,630.6 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling expense |
|
|
214.1 |
|
|
|
178.0 |
|
|
|
623.0 |
|
|
|
511.1 |
|
General and administrative expenses |
|
|
877.4 |
|
|
|
811.7 |
|
|
|
2,589.7 |
|
|
|
2,441.6 |
|
Interest expense |
|
|
32.5 |
|
|
|
25.9 |
|
|
|
90.2 |
|
|
|
76.6 |
|
Amortization of other acquired intangible assets |
|
|
15.9 |
|
|
|
9.3 |
|
|
|
38.1 |
|
|
|
34.7 |
|
Reduction of reserve for anticipated future losses on discontinued products |
|
|
|
|
|
|
|
|
|
|
(66.7 |
) |
|
|
|
|
|
Total benefits and expenses |
|
|
5,112.1 |
|
|
|
4,567.8 |
|
|
|
14,736.3 |
|
|
|
13,305.8 |
|
|
Income from continuing operations before income taxes |
|
|
588.6 |
|
|
|
471.7 |
|
|
|
1,888.2 |
|
|
|
1,430.0 |
|
Income taxes: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current |
|
|
187.3 |
|
|
|
51.4 |
|
|
|
539.9 |
|
|
|
410.1 |
|
Deferred |
|
|
23.5 |
|
|
|
118.0 |
|
|
|
136.8 |
|
|
|
105.5 |
|
|
Total income taxes |
|
|
210.8 |
|
|
|
169.4 |
|
|
|
676.7 |
|
|
|
515.6 |
|
|
Income from continuing operations |
|
|
377.8 |
|
|
|
302.3 |
|
|
|
1,211.5 |
|
|
|
914.4 |
|
Discontinued operations, net of tax (Note 16) |
|
|
|
|
|
|
990.0 |
|
|
|
|
|
|
|
1,030.0 |
|
|
Net income |
|
$ |
377.8 |
|
|
$ |
1,292.3 |
|
|
$ |
1,211.5 |
|
|
$ |
1,944.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per common share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
$ |
1.31 |
|
|
$ |
1.00 |
|
|
$ |
4.16 |
|
|
$ |
2.99 |
|
Discontinued operations, net of tax |
|
|
|
|
|
|
3.27 |
|
|
|
|
|
|
|
3.38 |
|
|
Net income |
|
$ |
1.31 |
|
|
$ |
4.27 |
|
|
$ |
4.16 |
|
|
$ |
6.37 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
$ |
1.26 |
|
|
$ |
.96 |
|
|
$ |
4.01 |
|
|
$ |
2.88 |
|
Discontinued operations, net of tax |
|
|
|
|
|
|
3.14 |
|
|
|
|
|
|
|
3.25 |
|
|
Net income |
|
$ |
1.26 |
|
|
$ |
4.10 |
|
|
$ |
4.01 |
|
|
$ |
6.13 |
|
|
*Other revenue includes administrative services contract member co-payment revenue and plan
sponsor reimbursements related to the Companys mail order pharmacy of $7.4 million and $15.5
million (net of pharmaceutical and processing costs of $226.2 million and $644.9 million) for the
three and nine months ended September 30, 2005, respectively, and $2.5 million and $10.6 million
(net of pharmaceutical and processing costs of $166.5 million and $450.1 million) for the three and
nine months ended September 30, 2004, respectively.
**Health care costs have been reduced by fully insured member co-payment revenue related to the
Companys mail order pharmacy of $20.5 million and $57.3 million for the three and nine months
ended September 30, 2005, respectively, and $15.0 million and $43.3 million for the three and nine
months ended September 30, 2004, respectively.
Refer to accompanying Condensed Notes to Consolidated Financial Statements.
Page 1
Consolidated Balance Sheets
|
|
|
|
|
|
|
|
|
|
|
At September 30, |
|
|
At December 31, |
|
(Millions, except share data) |
|
2005 |
|
|
2004 |
|
|
Assets |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
1,032.7 |
|
|
$ |
1,396.0 |
|
Investment securities |
|
|
13,356.2 |
|
|
|
14,242.6 |
|
Other investments |
|
|
58.4 |
|
|
|
57.7 |
|
Premiums receivable, net |
|
|
353.7 |
|
|
|
256.1 |
|
Other receivables, net |
|
|
469.7 |
|
|
|
314.0 |
|
Accrued investment income |
|
|
186.6 |
|
|
|
198.6 |
|
Collateral received under securities loan agreements |
|
|
1,274.7 |
|
|
|
1,173.8 |
|
Loaned securities |
|
|
1,248.9 |
|
|
|
1,150.1 |
|
Income taxes receivable |
|
|
81.6 |
|
|
|
226.8 |
|
Deferred income taxes |
|
|
180.4 |
|
|
|
196.0 |
|
Other current assets |
|
|
453.0 |
|
|
|
304.5 |
|
|
Total current assets |
|
|
18,695.9 |
|
|
|
19,516.2 |
|
|
Long-term investments |
|
|
1,763.6 |
|
|
|
1,718.1 |
|
Mortgage loans |
|
|
1,493.8 |
|
|
|
1,348.2 |
|
Investment real estate |
|
|
226.4 |
|
|
|
274.8 |
|
Reinsurance recoverables |
|
|
1,152.0 |
|
|
|
1,173.0 |
|
Goodwill |
|
|
4,369.6 |
|
|
|
3,687.8 |
|
Other acquired intangible assets, net |
|
|
769.6 |
|
|
|
460.3 |
|
Property and equipment, net |
|
|
251.5 |
|
|
|
233.6 |
|
Deferred income taxes |
|
|
183.0 |
|
|
|
300.0 |
|
Other long-term assets |
|
|
407.1 |
|
|
|
405.9 |
|
Separate Accounts assets |
|
|
13,945.0 |
|
|
|
13,015.8 |
|
|
Total assets |
|
$ |
43,257.5 |
|
|
$ |
42,133.7 |
|
|
|
|
|
|
|
|
|
|
|
Liabilities and shareholders equity |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Heath care costs payable |
|
$ |
1,864.8 |
|
|
$ |
1,927.1 |
|
Future policy benefits |
|
|
799.3 |
|
|
|
837.6 |
|
Unpaid claims |
|
|
738.9 |
|
|
|
707.7 |
|
Unearned premiums |
|
|
224.2 |
|
|
|
121.8 |
|
Policyholders funds |
|
|
595.9 |
|
|
|
672.5 |
|
Collateral payable under securities loan agreements |
|
|
1,274.7 |
|
|
|
1,173.8 |
|
Current portion of long-term debt |
|
|
449.9 |
|
|
|
|
|
Accrued expenses and other current liabilities |
|
|
1,765.3 |
|
|
|
1,570.8 |
|
|
Total current liabilities |
|
|
7,713.0 |
|
|
|
7,011.3 |
|
|
Future policy benefits |
|
|
7,695.5 |
|
|
|
7,859.5 |
|
Unpaid claims |
|
|
1,126.5 |
|
|
|
1,081.5 |
|
Policyholders funds |
|
|
1,507.2 |
|
|
|
1,453.1 |
|
Long-term debt, less current portion |
|
|
1,155.7 |
|
|
|
1,609.7 |
|
Other long-term liabilities |
|
|
794.5 |
|
|
|
1,021.4 |
|
Separate Accounts liabilities |
|
|
13,945.0 |
|
|
|
13,015.8 |
|
|
Total liabilities |
|
|
33,937.4 |
|
|
|
33,052.3 |
|
|
Commitments and contingencies (Note 13) |
|
|
|
|
|
|
|
|
Shareholders equity: |
|
|
|
|
|
|
|
|
Common stock and additional paid-in capital ($.01 par value, 1,446,996,969 shares authorized, 286,010,804 shares issued and outstanding in 2005 and $.01 par value, 732,492,499 shares authorized, 293,005,672 shares
issued and outstanding in 2004) |
|
|
2,222.1 |
|
|
|
3,076.5 |
|
Retained earnings |
|
|
7,746.5 |
|
|
|
6,546.4 |
|
Accumulated other comprehensive loss |
|
|
(648.5 |
) |
|
|
(541.5 |
) |
|
Total shareholders equity |
|
|
9,320.1 |
|
|
|
9,081.4 |
|
|
Total liabilities and shareholders equity |
|
$ |
43,257.5 |
|
|
$ |
42,133.7 |
|
|
Refer to accompanying Condensed Notes to Consolidated Financial Statements.
Page 2
Consolidated Statements of Shareholders Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of |
|
|
Common |
|
|
|
|
|
|
Accumulated |
|
|
|
|
|
|
|
|
|
Common |
|
|
Stock and |
|
|
|
|
|
|
Other |
|
|
Total |
|
|
|
|
|
|
Shares |
|
|
Additional |
|
|
Retained |
|
|
Comprehensive |
|
|
Shareholders |
|
|
Comprehensive |
|
(Millions, except per share data) |
|
Outstanding |
|
|
Paid-in Capital |
|
|
Earnings |
|
|
Income (Loss) |
|
|
Equity |
|
|
Income |
|
|
Nine Months Ended September 30, 2005 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2004 |
|
|
293,005,672 |
|
|
$ |
3,076.5 |
|
|
$ |
6,546.4 |
|
|
$ |
(541.5 |
) |
|
$ |
9,081.4 |
|
|
|
|
|
Comprehensive income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
|
|
|
|
|
|
|
|
|
1,211.5 |
|
|
|
|
|
|
|
1,211.5 |
|
|
$ |
1,211.5 |
|
Other comprehensive income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net unrealized losses on securities (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(104.8 |
) |
|
|
(104.8 |
) |
|
|
|
|
Net foreign currency gains |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
.8 |
|
|
|
.8 |
|
|
|
|
|
Net derivative losses (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3.0 |
) |
|
|
(3.0 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(107.0 |
) |
|
|
(107.0 |
) |
|
|
(107.0 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
1,104.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common shares issued for benefit plans |
|
|
9,293,161 |
|
|
|
384.0 |
|
|
|
|
|
|
|
|
|
|
|
384.0 |
|
|
|
|
|
Repurchases of common shares |
|
|
(16,288,029 |
) |
|
|
(1,238.4 |
) |
|
|
|
|
|
|
|
|
|
|
(1,238.4 |
) |
|
|
|
|
Dividends declared |
|
|
|
|
|
|
|
|
|
|
(11.4 |
) |
|
|
|
|
|
|
(11.4 |
) |
|
|
|
|
|
|
|
|
|
Balance at September 30, 2005 |
|
|
286,010,804 |
|
|
$ |
2,222.1 |
|
|
$ |
7,746.5 |
|
|
$ |
(648.5 |
) |
|
$ |
9,320.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30, 2004 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2003 |
|
|
305,156,502 |
|
|
$ |
4,024.8 |
|
|
$ |
4,307.2 |
|
|
$ |
(408.0 |
) |
|
$ |
7,924.0 |
|
|
|
|
|
Comprehensive income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
|
|
|
|
|
|
|
|
|
1,944.4 |
|
|
|
|
|
|
|
1,944.4 |
|
|
$ |
1,944.4 |
|
Other comprehensive loss: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net unrealized losses on securities (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(33.9 |
) |
|
|
(33.9 |
) |
|
|
|
|
Net foreign currency gains |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
.6 |
|
|
|
.6 |
|
|
|
|
|
Net derivative gains (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
.5 |
|
|
|
.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive loss |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(32.8 |
) |
|
|
(32.8 |
) |
|
|
(32.8 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
1,911.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common shares issued for benefit plans |
|
|
16,649,230 |
|
|
|
424.9 |
|
|
|
|
|
|
|
|
|
|
|
424.9 |
|
|
|
|
|
Repurchases of common shares |
|
|
(26,501,198 |
) |
|
|
(1,170.0 |
) |
|
|
|
|
|
|
|
|
|
|
(1,170.0 |
) |
|
|
|
|
Dividends declared |
|
|
|
|
|
|
|
|
|
|
(5.9 |
) |
|
|
|
|
|
|
(5.9 |
) |
|
|
|
|
|
|
|
|
|
Balance at September 30, 2004 |
|
|
295,304,534 |
|
|
$ |
3,279.7 |
|
|
$ |
6,245.7 |
|
|
$ |
(440.8 |
) |
|
$ |
9,084.6 |
|
|
|
|
|
|
|
|
|
|
(1)
|
|
Net of reclassification adjustments (refer to Note 8). |
Refer to accompanying Condensed Notes to Consolidated Financial Statements.
Page 3
Consolidated Statements of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended |
|
|
September 30, |
(Millions) |
|
2005 |
|
|
2004 |
|
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
Net income |
|
$ |
1,211.5 |
|
|
$ |
1,944.4 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
|
|
|
Discontinued operations |
|
|
|
|
|
|
(1,030.0 |
) |
Amortization of other acquired intangible assets |
|
|
38.1 |
|
|
|
34.7 |
|
Depreciation and amortization |
|
|
109.4 |
|
|
|
105.5 |
|
Amortization of net investment premium |
|
|
19.5 |
|
|
|
34.1 |
|
Net realized capital gains |
|
|
(18.6 |
) |
|
|
(51.5 |
) |
Changes in assets and liabilities: |
|
|
|
|
|
|
|
|
Decrease in accrued investment income |
|
|
12.0 |
|
|
|
11.1 |
|
Increase in premiums due and other receivables |
|
|
(106.7 |
) |
|
|
(6.0 |
) |
Net change in income taxes |
|
|
457.4 |
|
|
|
224.0 |
|
Net change in other assets and other liabilities |
|
|
(383.1 |
) |
|
|
(686.4 |
) |
Decrease in health care and insurance liabilities |
|
|
(60.4 |
) |
|
|
(278.7 |
) |
Other, net |
|
|
(32.4 |
) |
|
|
(9.8 |
) |
|
Net cash provided by operating activities of continuing operations |
|
|
1,246.7 |
|
|
|
291.4 |
|
Discontinued operations, net (Note 16) |
|
|
|
|
|
|
666.2 |
|
|
Net cash provided by operating activities |
|
|
1,246.7 |
|
|
|
957.6 |
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
Proceeds from sales and investment maturities of: |
|
|
|
|
|
|
|
|
Debt securities available for sale |
|
|
8,002.9 |
|
|
|
7,265.1 |
|
Other investments |
|
|
874.1 |
|
|
|
2,029.9 |
|
Cost of investments in: |
|
|
|
|
|
|
|
|
Debt securities available for sale |
|
|
(7,497.2 |
) |
|
|
(7,087.4 |
) |
Other investments |
|
|
(798.4 |
) |
|
|
(1,891.9 |
) |
Increase in property, equipment and software |
|
|
(183.1 |
) |
|
|
(134.5 |
) |
Cash used for acquisitions, net of cash acquired |
|
|
(1,021.5 |
) |
|
|
|
|
|
Net cash (used for) provided by investing activities |
|
|
(623.2 |
) |
|
|
181.2 |
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
Deposits and interest credited for investment contracts |
|
|
30.6 |
|
|
|
42.7 |
|
Withdrawals of investment contracts |
|
|
(30.2 |
) |
|
|
(381.7 |
) |
Common shares issued under benefit plans |
|
|
223.5 |
|
|
|
256.4 |
|
Common shares repurchased |
|
|
(1,210.7 |
) |
|
|
(1,132.7 |
) |
Other, net |
|
|
|
|
|
|
10.0 |
|
|
Net cash used for financing activities |
|
|
(986.8 |
) |
|
|
(1,205.3 |
) |
|
|
|
|
|
|
|
|
|
|
Net decrease in cash and cash equivalents |
|
|
(363.3 |
) |
|
|
(66.5 |
) |
Cash and cash equivalents, beginning of period |
|
|
1,396.0 |
|
|
|
1,433.4 |
|
|
Cash and cash equivalents, end of period |
|
$ |
1,032.7 |
|
|
$ |
1,366.9 |
|
|
|
|
|
|
|
|
|
|
|
Supplemental cash flow information: |
|
|
|
|
|
|
|
|
Interest paid |
|
$ |
105.5 |
|
|
$ |
93.5 |
|
Income taxes paid (received) |
|
|
218.5 |
|
|
|
(372.9 |
) |
|
Refer to accompanying Condensed Notes to Consolidated Financial Statements.
Page 4
Condensed Notes to Consolidated Financial Statements
1. Organization
The accompanying consolidated financial statements include Aetna Inc. (a Pennsylvania corporation)
(Aetna) and its subsidiaries (collectively, the Company). The Companys operations include
three business segments: Health Care, Group Insurance and Large Case Pensions. Health Care
consists of medical and dental plans offered on both a risk basis (where the Company assumes all or
a majority of the risk for medical and dental care costs) and an employer-funded basis (where the
plan sponsor under an administrative services contract (ASC) assumes all or a majority of this
risk). Medical plans include point-of-service (POS), health maintenance organization (HMO),
preferred provider organization (PPO) and indemnity benefit (Indemnity) products. Health plans
also include Health Savings Accounts (HSAs) and Aetna HealthFund®, consumer-directed
plans that combine traditional POS or PPO and/or dental coverage, subject to a deductible, with an
accumulating benefit account (which may be funded by the plan sponsor or member in the case of
HSAs). The Group Insurance segment includes group life insurance products offered on a risk basis,
as well as group disability and long-term care insurance products offered on both a risk and an
employer-funded basis. Large Case Pensions manages a variety of retirement products (including
pension and annuity products) primarily for defined benefit and defined contribution plans. These
products provide a variety of funding and benefit payment distribution options and other services.
The Large Case Pensions segment includes certain discontinued products (refer to Note 15 for
additional information).
On February 9, 2005, the Board of Directors declared a two-for-one stock split of the Companys
common stock effected in the form of a 100% common stock dividend. All shareholders of record
on February 25, 2005 received one additional share of common stock for each share held on that
date. The additional shares of common stock were distributed to shareholders of record in the
form of a stock dividend on March 11, 2005. All share and per share amounts in the accompanying
consolidated financial statements and related notes have been adjusted to reflect the stock
split for all periods presented.
These interim statements necessarily rely heavily on estimates, including assumptions as to
annualized tax rates. In the opinion of management, all adjustments necessary for a fair statement of results for the
interim periods have been made. All such adjustments are of a normal, recurring nature. The
accompanying consolidated financial statements and related notes should be read in conjunction with
the consolidated financial statements and related notes presented in Aetnas 2004 Annual Report on
Form 10-K (the 2004 Annual Report). Certain financial information that is normally included in
annual financial statements prepared in accordance with U.S. generally accepted accounting
principles (GAAP), but that is not required for interim reporting purposes, has been condensed or
omitted.
2. Summary of Significant Accounting Policies
Principles of Consolidation
These unaudited consolidated financial statements have been prepared in accordance with GAAP and
include the accounts of Aetna and subsidiaries that the Company controls. All significant
intercompany balances have been eliminated in consolidation.
Future Application of Accounting Standard
Accounting for Stock-Based Compensation
In December 2004, the Financial Accounting Standards Board issued Statement of Financial Accounting
Standards (FAS) No. 123-Revised, Share-Based Payment (FAS 123-R). FAS 123-R requires
companies to charge the fair value of all share-based payment awards (including stock options)
issued to employees and non-employees to expense. The provisions of this standard require the fair
value to be calculated using a valuation model (such as the Black-Scholes or binomial-lattice
models). The provisions of this standard are effective for all new share-based arrangements
entered into in the first quarter of 2006, as well as the fair value of the unvested portion of
existing arrangements as of January 1, 2006. The estimated fair value of the unvested portion of
existing arrangements as of January 1, 2006 is expected to be approximately $30 million, of which
approximately $16 million will be expensed in 2006 in addition to the fair value of any future
grants.
Page 5
Stock-Based Compensation
At September 30, 2005, the Company had various stock-based employee incentive plans, which are
described more fully in Note 13 to the consolidated financial statements presented in the 2004
Annual Report. The Company uses the intrinsic value method of accounting for stock-based awards
granted to employees. Accordingly, compensation cost is not recognized when the exercise price of
an employee stock option equals or exceeds the fair value of the stock on the date the option is
granted. The following table illustrates the pro forma net income and pro forma earnings per
common share as if the Company had applied the fair value based method of accounting to all awards
of stock-based employee compensation for the three and nine months ended September 30, 2005 and
2004. The Company uses a modified Black-Scholes option pricing model to estimate fair value.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
September 30, |
|
|
September 30, |
(Millions, except per common share data) |
|
2005 |
|
|
2004 |
|
|
2005 |
|
|
2004 |
|
|
Net income, as reported |
|
$ |
377.8 |
|
|
$ |
1,292.3 |
|
|
$ |
1,211.5 |
|
|
$ |
1,944.4 |
|
Add: Stock-based employee compensation expense included in
reported net income, net of related taxes |
|
|
.1 |
|
|
|
2.8 |
|
|
|
.4 |
|
|
|
9.7 |
|
Deduct: Total stock-based employee compensation expense determined
under fair value based method for all awards, net of related taxes |
|
|
(5.1 |
) |
|
|
(26.7 |
) |
|
|
(54.9 |
) |
|
|
(73.7 |
) |
|
Pro forma net income |
|
$ |
372.8 |
|
|
$ |
1,268.4 |
|
|
$ |
1,157.0 |
|
|
$ |
1,880.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per common share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic as reported |
|
$ |
1.31 |
|
|
$ |
4.27 |
|
|
$ |
4.16 |
|
|
$ |
6.37 |
|
Basic pro forma |
|
|
1.29 |
|
|
|
4.20 |
|
|
|
3.98 |
|
|
|
6.16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted as reported |
|
|
1.26 |
|
|
|
4.10 |
|
|
|
4.01 |
|
|
|
6.13 |
|
Diluted pro forma |
|
|
1.24 |
|
|
|
4.03 |
|
|
|
3.82 |
|
|
|
5.93 |
|
|
3. Acquisitions
In January 2005, the Company acquired Strategic Resource Company (SRC), a privately held
administrator of group limited benefit products for part-time and hourly workers. For
approximately $252 million, financed through available cash, Aetna acquired 100% of the stock of
SRC and reinsured the insurance contracts administered by SRC. Approximately $67 million of the
purchase price is currently held in escrow pending resolution of certain future events. The
Company recorded approximately $82 million of intangible assets (primarily customer lists) and
approximately $128 million of goodwill, which represents the purchase price in excess of the fair
value of the net assets acquired.
In May 2005, the Company acquired Active Health Management, Inc. (Active Health), a privately
held health management and health care data analytics company, for approximately $405 million,
financed through available cash. The Company preliminarily recorded approximately $89 million of intangible
assets (primarily customer lists, technology and trademarks) and goodwill of approximately $311
million, which represents the purchase price in excess of the fair value of the net assets
acquired.
In July 2005, the Company acquired HMS Healthcare, Inc. (HMS), a privately held regional health
care network, primarily in Michigan and Colorado, for approximately $390 million, financed through
available cash. In the third quarter of 2005, the Company has preliminarily recorded
approximately $176 million of intangible assets (primarily
customer lists and tradenames) and
goodwill of approximately $240 million, which represents the purchase price in excess of the fair
value of the net assets acquired.
The Companys intangible assets and goodwill associated with the acquisitions of Active Health and
HMS are subject to adjustment upon completion of purchase accounting valuations.
In
October 2005, the Company announced its intention to exercise its
option to purchase the remaining 60% ownership interest in
Aetna Speciality Pharmacy, LLC (ASP) from its venture
partner, Priority Healthcare Corporation. As a result of this
purchase, which is subject to federal antitrust regulatory approval, the Company would own 100% of
ASP. The purchase price is not material to the Company. Refer to
Note 3 to the consolidated financial statements presented in the
2004 Annual Report for additional information.
Page 6
4. Earnings Per Common Share
A reconciliation of the numerator and denominator of the basic and diluted earnings per common
share (EPS) for the three and nine months ended September 30, 2005 and 2004 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income |
|
|
Shares |
|
|
Per Common |
|
(Millions, except EPS data) |
|
(Numerator) |
|
|
(Denominator) |
|
|
Share Amount |
|
|
Three Months Ended September 30, 2005 |
|
|
|
|
|
|
|
|
|
|
|
|
Basic EPS: |
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
$ |
377.8 |
|
|
|
288.7 |
|
|
$ |
1.31 |
|
Effect of dilutive securities: |
|
|
|
|
|
|
|
|
|
|
|
|
Stock options and other |
|
|
|
|
|
|
12.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted EPS: |
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations and assumed conversions |
|
$ |
377.8 |
|
|
|
300.7 |
|
|
$ |
1.26 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, 2004 |
|
|
|
|
|
|
|
|
|
|
|
|
Basic EPS: |
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
$ |
302.3 |
|
|
|
302.3 |
|
|
$ |
1.00 |
|
Effect of dilutive securities: |
|
|
|
|
|
|
|
|
|
|
|
|
Stock options and other |
|
|
|
|
|
|
12.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted EPS: |
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations and assumed conversions |
|
$ |
302.3 |
|
|
|
314.8 |
|
|
$ |
.96 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30, 2005 |
|
|
|
|
|
|
|
|
|
|
|
|
Basic EPS: |
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
$ |
1,211.5 |
|
|
|
290.9 |
|
|
$ |
4.16 |
|
Effect of dilutive securities: |
|
|
|
|
|
|
|
|
|
|
|
|
Stock options and other |
|
|
|
|
|
|
11.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted EPS: |
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations and assumed conversions |
|
$ |
1,211.5 |
|
|
|
302.4 |
|
|
$ |
4.01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30, 2004 |
|
|
|
|
|
|
|
|
|
|
|
|
Basic EPS: |
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
$ |
914.4 |
|
|
|
305.5 |
|
|
$ |
2.99 |
|
Effect of dilutive securities: |
|
|
|
|
|
|
|
|
|
|
|
|
Stock options and other |
|
|
|
|
|
|
11.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted EPS: |
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations and assumed conversions |
|
$ |
914.4 |
|
|
|
317.1 |
|
|
$ |
2.88 |
|
|
5. Operating Expenses
For the three and nine months ended September 30, 2005 and 2004, selling expenses (which include
broker commissions, the variable component of the Companys internal sales force compensation and
premium taxes) and general and administrative expenses were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
September 30, |
|
|
September 30, |
(Millions) |
|
2005 |
|
|
2004 |
|
|
2005 |
|
|
2004 |
|
|
Selling expenses |
|
$ |
214.1 |
|
|
$ |
178.0 |
|
|
$ |
623.0 |
|
|
$ |
511.1 |
|
|
General and administrative expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and related benefits |
|
|
533.3 |
|
|
|
499.6 |
|
|
|
1,591.1 |
|
|
|
1,507.4 |
(1) |
Other general and administrative expenses |
|
|
344.1 |
|
|
|
312.1 |
|
|
|
998.6 |
|
|
|
934.2 |
|
|
Total general and administrative expenses |
|
|
877.4 |
|
|
|
811.7 |
|
|
|
2,589.7 |
|
|
|
2,441.6 |
|
|
Total operating expenses |
|
$ |
1,091.5 |
|
|
$ |
989.7 |
|
|
$ |
3,212.7 |
|
|
$ |
2,952.7 |
|
|
(1)
|
|
Salaries and related benefits for the nine months ended
September 30, 2004 include a curtailment benefit of
$31.8 million related to the elimination of the dental
subsidy for all retirees. |
Page 7
6. Other Acquired Intangible Assets
Other acquired intangible assets at September 30, 2005 and December 31, 2004 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated |
|
|
|
|
|
|
Amortization |
|
(Millions) |
|
Cost |
|
|
Amortization |
|
|
Net Balance |
|
|
Period (Years) |
|
|
September 30, 2005 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other acquired intangible assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Customer lists |
|
$ |
1,199.3 |
|
|
$ |
929.5 |
|
|
$ |
269.8 |
|
|
|
5-9 |
|
Provider networks |
|
|
680.2 |
|
|
|
246.1 |
|
|
|
434.1 |
|
|
|
20-25 |
|
Technology |
|
|
32.1 |
|
|
|
3.0 |
|
|
|
29.1 |
|
|
|
3-5 |
|
Other |
|
|
16.4 |
|
|
|
2.1 |
|
|
|
14.3 |
|
|
|
3-5 |
|
Trademarks
and tradenames (indefinite lived) |
|
|
22.3 |
|
|
|
|
|
|
|
22.3 |
|
|
Indefinite |
|
|
|
|
|
Total other acquired intangible assets (1) |
|
$ |
1,950.3 |
|
|
$ |
1,180.7 |
|
|
$ |
769.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2004 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other acquired intangible assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Customer lists |
|
$ |
919.0 |
|
|
$ |
917.5 |
|
|
$ |
1.5 |
|
|
|
5-7 |
|
Provider networks |
|
|
679.9 |
|
|
|
225.1 |
|
|
|
454.8 |
|
|
|
20-25 |
|
Other |
|
|
4.0 |
|
|
|
|
|
|
|
4.0 |
|
|
|
3-5 |
|
|
|
|
|
|
Total other acquired intangible assets |
|
$ |
1,602.9 |
|
|
$ |
1,142.6 |
|
|
$ |
460.3 |
|
|
|
|
|
|
|
|
|
|
(1)
|
|
Other acquired intangible assets include $88.7 million and $176.0 million related
to the acquisitions of Active Health and HMS, respectively, that are considered preliminary,
pending the finalization of purchase accounting valuations (refer to Note 3 for additional
information). |
Annual pretax amortization for other acquired intangible assets over the next five calendar
years is estimated to be as follows:
|
|
|
|
|
(Millions) |
|
|
|
|
2006 |
|
$ |
67.1 |
|
2007 |
|
|
66.5 |
|
2008 |
|
|
61.7 |
|
2009 |
|
|
57.3 |
|
2010 |
|
|
55.1 |
|
|
7. Investments
Total investments at September 30, 2005 and December 31, 2004 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2005 |
|
|
December 31, 2004 |
|
(Millions) |
|
Current |
|
|
Long-term |
|
|
Total |
|
|
Current |
|
|
Long-term |
|
|
Total |
|
|
Debt securities available for sale: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Available for use in current operations |
|
$ |
13,217.8 |
(1) |
|
$ |
|
|
|
$ |
13,217.8 |
|
|
$ |
14,013.6 |
(1) |
|
$ |
|
|
|
$ |
14,013.6 |
|
Loaned securities |
|
|
1,248.9 |
|
|
|
|
|
|
|
1,248.9 |
|
|
|
1,150.1 |
|
|
|
|
|
|
|
1,150.1 |
|
On deposit, as required by regulatory
authorities |
|
|
|
|
|
|
525.8 |
(3) |
|
|
525.8 |
|
|
|
|
|
|
|
553.4 |
(3) |
|
|
553.4 |
|
|
Debt securities available for sale |
|
|
14,466.7 |
|
|
|
525.8 |
|
|
|
14,992.5 |
|
|
|
15,163.7 |
|
|
|
553.4 |
|
|
|
15,717.1 |
|
Equity securities available for sale |
|
|
33.2 |
(1) |
|
|
36.0 |
(3) |
|
|
69.2 |
|
|
|
34.5 |
(1) |
|
|
40.2 |
(3) |
|
|
74.7 |
|
Short-term investments |
|
|
105.2 |
(1) |
|
|
|
|
|
|
105.2 |
|
|
|
194.5 |
(1) |
|
|
|
|
|
|
194.5 |
|
Mortgage loans |
|
|
36.0 |
(2) |
|
|
1,493.8 |
|
|
|
1,529.8 |
|
|
|
52.7 |
(2) |
|
|
1,348.2 |
|
|
|
1,400.9 |
|
Investment real estate |
|
|
|
|
|
|
226.4 |
|
|
|
226.4 |
|
|
|
|
|
|
|
274.8 |
|
|
|
274.8 |
|
Other investments |
|
|
22.4 |
(2) |
|
|
1,201.8 |
(3) |
|
|
1,224.2 |
|
|
|
5.0 |
(2) |
|
|
1,124.5 |
(3) |
|
|
1,129.5 |
|
|
Total investments |
|
$ |
14,663.5 |
|
|
$ |
3,483.8 |
|
|
$ |
18,147.3 |
|
|
$ |
15,450.4 |
|
|
$ |
3,341.1 |
|
|
$ |
18,791.5 |
|
|
(1)
|
|
Included in investment securities on the Consolidated
Balance Sheets totaling $13.4 billion and $14.2 billion at
September 30, 2005 and December 31, 2004, respectively. |
(2)
|
|
Included in other investments on the Consolidated Balance
Sheets totaling $58.4 million and $57.7 million at September
30, 2005 and December 31, 2004, respectively. |
(3)
|
|
Included in long-term investments on the Consolidated
Balance Sheets totaling $1.8 billion and $1.7 billion at
September 30, 2005 and December 31, 2004, respectively. |
Page 8
Sources of net investment income for the three and nine months ended September 30, 2005 and
2004 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
September 30, |
|
|
September 30, |
(Millions) |
|
2005 |
|
|
2004 |
|
|
2005 |
|
|
2004 |
|
|
Debt securities |
|
$ |
204.4 |
|
|
$ |
212.7 |
|
|
$ |
634.8 |
|
|
$ |
655.8 |
|
Mortgage loans |
|
|
34.5 |
|
|
|
31.9 |
|
|
|
98.0 |
|
|
|
96.5 |
|
Other |
|
|
38.6 |
|
|
|
12.7 |
|
|
|
87.9 |
|
|
|
43.3 |
|
Cash equivalents and other short-term investments |
|
|
15.3 |
|
|
|
8.1 |
|
|
|
40.4 |
|
|
|
19.2 |
|
Equity securities |
|
|
.8 |
|
|
|
.8 |
|
|
|
1.7 |
|
|
|
1.6 |
|
Investment real estate |
|
|
(3.9 |
) |
|
|
(2.4 |
) |
|
|
(7.3 |
) |
|
|
(6.0 |
) |
|
Gross investment income |
|
|
289.7 |
|
|
|
263.8 |
|
|
|
855.5 |
|
|
|
810.4 |
|
Less: investment expenses |
|
|
(9.8 |
) |
|
|
(9.9 |
) |
|
|
(27.8 |
) |
|
|
(24.8 |
) |
|
Net investment income (1) |
|
$ |
279.9 |
|
|
$ |
253.9 |
|
|
$ |
827.7 |
|
|
$ |
785.6 |
|
|
(1)
|
|
Includes amounts related to experience-rated contractholders
of $36.5 million and $110.4 million during the three and
nine months ended September 30, 2005, respectively, and
$39.8 million and $118.3 million during the three and nine
months ended September 30, 2004, respectively. Interest
credited to experience-rated contractholders is included in
current and future benefits. |
Net realized capital gains for the three and nine months ended September 30, 2005 and 2004,
excluding amounts related to experience-rated contractholders and discontinued products, on
investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
September 30, |
|
|
September 30, |
(Millions) |
|
2005 |
|
|
2004 |
|
|
2005 |
|
|
2004 |
|
|
Debt securities |
|
$ |
11.1 |
|
|
$ |
21.4 |
|
|
$ |
14.5 |
|
|
$ |
46.4 |
|
Equity securities |
|
|
|
|
|
|
.3 |
|
|
|
|
|
|
|
7.1 |
|
Other |
|
|
(2.6 |
) |
|
|
(2.1 |
) |
|
|
4.1 |
|
|
|
(2.0 |
) |
|
Pretax net realized capital gains |
|
$ |
8.5 |
|
|
$ |
19.6 |
|
|
$ |
18.6 |
|
|
$ |
51.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
After tax net realized capital gains |
|
$ |
5.5 |
|
|
$ |
12.8 |
|
|
$ |
12.1 |
|
|
$ |
33.5 |
|
|
Net realized capital gains (losses) of $5 million and $3 million for the three and nine months
ended September 30, 2005, respectively, and $(.6) million and $11 million for the three and nine
months ended September 30, 2004, respectively, related to experience-rated contractholders were
deducted from net realized capital gains, and an offsetting amount is reflected in policyholders
funds. Net realized capital gains of $12 million for both the three and nine months ended
September 30, 2005, and $7 million and $21 million for the three and nine months ended September
30, 2004, respectively, related to discontinued products were deducted from net realized capital
gains, and an offsetting amount is reflected in the reserve for anticipated future losses on
discontinued products.
8. Other Comprehensive Income (Loss)
Changes in accumulated other comprehensive income (loss) related to changes in net unrealized gains
(losses) on securities (excluding those related to experience-rated contractholders and
discontinued products) for the nine months ended September 30, 2005 and 2004 were as follows:
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended |
|
|
September 30, |
(Millions) |
|
2005 |
|
|
2004 |
|
|
Securities: |
|
|
|
|
|
|
|
|
Net unrealized holding losses arising during the period (1) |
|
$ |
(108.0 |
) |
|
$ |
(21.3 |
) |
Less: reclassification adjustment for gains (losses) included in net income (2) |
|
|
(3.2 |
) |
|
|
12.6 |
|
|
Net unrealized losses on securities |
|
$ |
(104.8 |
) |
|
$ |
(33.9 |
) |
|
(1)
|
|
Pretax net unrealized holding losses arising during the nine
months ended September 30, 2005 and 2004 were $166.2 million
and $32.8 million, respectively. |
(2)
|
|
Pretax reclassification adjustments for (losses) gains
included in net income were $(4.9) million and $19.4 million
for the nine months ended September 30, 2005 and 2004,
respectively. |
Page 9
Changes in accumulated other comprehensive income (loss) related to changes in derivatives
gains (losses) for the nine months ended September 30, 2005 and 2004 were as follows:
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended |
|
|
September 30, |
(Millions) |
|
2005 |
|
|
2004 |
|
|
Derivatives: |
|
|
|
|
|
|
|
|
Net derivative losses arising during the period (1) |
|
$ |
(4.3 |
) |
|
$ |
|
|
Less: reclassification adjustment for losses included in net income (2) |
|
|
(1.3 |
) |
|
|
(.5 |
) |
|
Net derivative (losses) gains |
|
$ |
(3.0 |
) |
|
$ |
.5 |
|
|
(1) |
|
Pretax net derivative losses arising during the nine months ended September 30, 2005 were $6.5 million. |
|
(2) |
|
Pretax reclassification adjustments for gains (losses) included in net income were $(2.0) million and
$.7 million for the nine months ended September 30, 2005 and 2004, respectively. |
9. Benefit Plans
Components of the net periodic benefit cost of the Companys noncontributory defined benefit
pension plans for the three and nine months ended September 30, 2005 and 2004 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
September 30, |
|
|
September 30, |
(Millions) |
|
2005 |
|
|
2004 |
|
|
2005 |
|
|
2004 |
|
|
Service cost |
|
$ |
23.2 |
|
|
$ |
19.0 |
|
|
$ |
69.6 |
|
|
$ |
57.0 |
|
Interest cost |
|
|
68.5 |
|
|
|
65.4 |
|
|
|
205.5 |
|
|
|
196.0 |
|
Expected return on plan assets |
|
|
(92.6 |
) |
|
|
(77.7 |
) |
|
|
(277.8 |
) |
|
|
(232.9 |
) |
Amortization of prior service cost |
|
|
1.3 |
|
|
|
1.4 |
|
|
|
3.9 |
|
|
|
4.2 |
|
Recognized net actuarial loss |
|
|
18.6 |
|
|
|
16.1 |
|
|
|
55.8 |
|
|
|
48.1 |
|
|
Net periodic benefit cost |
|
$ |
19.0 |
|
|
$ |
24.2 |
|
|
$ |
57.0 |
|
|
$ |
72.4 |
|
|
Components of the net periodic benefit cost of the Companys other post-retirement benefit
plans for the three and nine months ended September 30, 2005 and 2004 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
September 30, |
|
|
September 30, |
(Millions) |
|
2005 |
|
|
2004 |
|
|
2005 |
|
|
2004 |
|
|
Service cost |
|
$ |
.1 |
|
|
$ |
.1 |
|
|
$ |
.3 |
|
|
$ |
.3 |
|
Interest cost |
|
|
7.0 |
|
|
|
6.0 |
|
|
|
21.0 |
|
|
|
19.0 |
|
Expected return on plan assets |
|
|
(1.1 |
) |
|
|
(1.1 |
) |
|
|
(3.3 |
) |
|
|
(3.3 |
) |
Amortization of prior service cost |
|
|
(.3 |
) |
|
|
(.4 |
) |
|
|
(.9 |
) |
|
|
(1.0 |
) |
Recognized net actuarial loss |
|
|
1.5 |
|
|
|
.2 |
|
|
|
4.5 |
|
|
|
1.2 |
|
|
Net periodic benefit cost before curtailment benefit |
|
|
7.2 |
|
|
|
4.8 |
|
|
|
21.6 |
|
|
|
16.2 |
|
Curtailment benefit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(31.8 |
) (1) |
|
Net periodic benefit cost (income) |
|
$ |
7.2 |
|
|
$ |
4.8 |
|
|
$ |
21.6 |
|
|
$ |
(15.6 |
) |
|
|
|
|
(1) |
|
Reflects a plan amendment made in January 2004 to eliminate the dental subsidy for all
retirees. Refer to Note 13 of the consolidated
financial statements presented in the 2004 Annual
Report for additional information. |
10. Debt
The carrying value of long-term debt at September 30, 2005 and December 31, 2004 was as
follows:
|
|
|
|
|
|
|
|
|
|
|
September 30, |
|
|
December 31, |
|
(Millions) |
|
2005 |
|
|
2004 |
|
|
Senior notes, 7.375%, due 2006 |
|
$ |
449.9 |
|
|
$ |
449.6 |
|
Senior notes, 7.875%, due 2011 |
|
|
448.0 |
|
|
|
447.7 |
|
Senior notes, 8.50%, due 2041 |
|
|
707.7 |
|
|
|
712.4 |
|
|
Total long-term debt |
|
|
1,605.6 |
|
|
|
1,609.7 |
|
Less current portion of long-term debt (1) |
|
|
(449.9 |
) |
|
|
|
|
|
Long-term debt, less current portion |
|
$ |
1,155.7 |
|
|
$ |
1,609.7 |
|
|
|
|
|
(1) |
|
At September 30, 2005, there were no short-term
borrowings outstanding. The 7.375% senior notes due
March 2006 have been classified as current in the
accompanying consolidated balance sheet as of September
30, 2005. |
Page 10
The Companys revolving credit facility contains financial covenants. Under the terms of the
facility, the Company is required to maintain a minimum level of shareholders equity, excluding
any minimum pension liability adjustment and any net unrealized capital gains and losses (Adjusted
Consolidated Net Worth), as of each fiscal quarter end. The required minimum level is increased
by 50% of the Companys consolidated net income each quarter beginning with the quarter ending
December 31, 2004. At September 30, 2005, the Company met its required minimum level of Adjusted
Consolidated Net Worth of approximately $7.5 billion. The Company is also required to maintain its
ratio of total debt to consolidated capitalization as of each fiscal quarter end at or below .4 to
1.0. For this purpose, consolidated capitalization equals the sum of Adjusted Consolidated Net
Worth and total debt (as defined in the facility). The Company met this requirement at September
30, 2005.
During
the three months ended September 30, 2005, the Company entered
into two forward starting swaps in
order to hedge the change in cash flows associated with interest payments generated by the
forecasted future issuance of long-term debt (expected to be issued between September 30, 2005 and
December 31, 2006). These transactions qualify as cash flow hedges in accordance with the
Companys accounting policy for derivatives. The changes in the fair value of the forward starting
swaps are expected to be highly effective in offsetting changes in the future cash flows (i.e.,
changes in interest payments) attributable to fluctuations in the benchmark LIBOR swap curve
interest rates. The swaps have a combined notional value of $500 million.
At September 30, 2005, and during the three months then ended, the cash flow hedges did not
experience any ineffectiveness. Based on the Companys assessment, the cash flow hedges remain
effective. As a result, at September 30, 2005, the Company recorded a liability of $4.2 million
(representing the fair value of the forward starting swaps), a charge to accumulated other
comprehensive income of $2.7 million, and a deferred tax asset of $1.5 million. Subsequent to the
issuance of the forecasted future debt, any balance remaining in accumulated other comprehensive
income will be amortized or accreted into earnings.
In December 2002, the Company entered into an interest rate swap agreement to convert the fixed
rate of 8.5% on $200 million of its senior notes to a variable rate of three-month LIBOR plus 254.0
basis points. In December 2001, the Company entered into an interest rate swap agreement to
convert the fixed rate of 8.5% on $350 million of its senior notes to a variable rate of
three-month LIBOR plus 159.5 basis points. Based on the terms of the swap agreements, they
qualified as fair value hedges. In May 2005, the Company sold both of these interest rate swap
agreements. At the time of the sale of the interest rate swap agreements, the cumulative fair
value adjustment of the debt on the balance sheet was a gain of $7.8 million. As a result of the
sale, the cumulative fair value adjustment will be amortized as a reduction of interest expense
over the remaining life of the applicable senior notes.
11. Capital Stock
On September 24, 2004, February 25, 2005 and September 29, 2005, the Board of Directors authorized
three share repurchase programs for the repurchase of up to $750 million of common stock each
($2.25 billion in aggregate). During the nine months ended September 30, 2005, the Company
repurchased approximately 16.3 million shares of common stock at a cost of approximately $1.2
billion (approximately $28 million of these repurchase transactions were settled in early October
2005), completing the September 24, 2004 authorization and utilizing a portion of the February 25,
2005 authorization. At September 30, 2005, the Company had authorization to repurchase up to
approximately $1.0 billion of common stock remaining under the February 25, 2005 and September 29,
2005 authorizations.
On February 11, 2005, the Board of Directors Committee on Compensation and Organization (the
Compensation Committee) granted approximately 4.0 million stock options to employees to purchase
common shares of the Company at $66.75 per share. The February 11, 2005 grants will become 100%
vested three years from the grant date, with one-third of the options vesting on June 30, 2005 and
the remaining options vesting on the second and third anniversaries of the grant date. During the
nine months ended September 30, 2005, the Company issued approximately 9.3 million common shares
for benefit plans, predominantly related to stock option exercises.
In connection with the stock split described in Note 1, the Board of Directors approved an
amendment to the Companys Articles of Incorporation. The amendment increased the number of
authorized common shares of the Company to 1,459,384,998 shares effective March 11, 2005 (which has
subsequently been reduced due to the Companys share repurchase activity). This increase is in the same proportion that the shares
distributed in the stock dividend increased the number of issued common shares.
Page 11
On September 29, 2005, the Board of Directors declared an annual cash dividend of $.04 per share to
shareholders of record at the close of business on November 16, 2005. The dividend will be paid on
November 30, 2005.
Under the Aetna Inc. Employee Stock Purchase Plan (the ESPP), 11.8 million of the Companys
common shares are reserved for issuance at September 30, 2005 in accordance with the ESPPs
provisions. Employee contributions are accumulated for a six-month period and used to purchase
stock at the end of the offering period. A six-month accumulation period commenced on December 20,
2004 and ended on June 17, 2005. The purchase price for this offering was at a 10% discount from
the lesser of the stocks fair market value on December 20, 2004 or June 17, 2005. During the six
months ended June 30, 2005, approximately 150,000 shares of common stock were purchased under the
ESPP at the purchase price of $55.60 per share. On June 20, 2005, another six-month accumulation
period commenced. This accumulation period ends on December 16, 2005, and the purchase price for
this offering is at a 10% discount from the lesser of the stocks fair market value on June 20,
2005 or December 16, 2005.
12. Dividend Restrictions and Statutory Surplus
Under regulatory requirements, the amount of dividends that may be paid through the end of 2005 to
Aetna by its insurance and HMO subsidiaries without prior approval by regulatory authorities is
approximately $261 million in the aggregate. There are no such restrictions on distributions from
Aetna to its shareholders.
At September 30, 2005, the combined statutory surplus of the Companys insurance and HMO
subsidiaries was $4.4 billion. At December 31, 2004, such surplus was $4.0 billion.
13. Commitments and Contingencies
New York Market Stabilization Pool
During the nine months ended September 30, 2005, the Company, certain other carriers and the New
York State Insurance Department entered into an agreement as to the Companys participation in the
New York State Market Stabilization Pool under New York Regulation 146 (Regulation 146) for the
years 1999 through 2004. Regulation 146 requires all carriers with small group and/or individual
business in New York State to participate in a market stabilization pooling mechanism under which
carriers that experience higher than average cost factors in providing services to members with
specified medical conditions receive payments from the pool, and carriers that experience lower
than average cost factors make payments to the pool. From 1999 through 2004, in the absence of any
pool data regarding relative average cost factors of the carriers doing business in New York State,
the Company made provisions for its estimate of liabilities incurred in this pool based on
discussions with the New York State Insurance Department and historical experience. As of December
31, 2004, the Company had recorded reserves (included in health care costs payable) of
approximately $89 million based on these estimates.
In June 2005, the Company and other carriers participating in the pool, along with the New York
State Insurance Department, entered into an agreement that modified the mechanism by which the
amounts due to (or receivable from) the pool were to be settled. Under this agreement, the Company
was a net receiver of approximately $14 million in cash from the pool in satisfaction of all of the
Companys remaining obligations relating to the pool for the years 1999 through 2004. Accordingly,
during the nine months ended September 30, 2005, the Company released the $89 million liability
recorded as of December 31, 2004, resulting in a $103 million pretax reduction in health care costs
during the nine months ended September 30, 2005. This agreement also eliminates any further payment
obligation by the Company for 2005. The New York State Insurance Department intends to propose a
new pooling mechanism for years subsequent to 2005.
Litigation
Managed Care Class Action Litigation
From 1999 through early 2003, the Company was involved in purported class action lawsuits as part
of a wave of similar actions targeting the health care payor industry and, in particular, the
conduct of business by managed care companies. These cases, brought on behalf of health care
providers (the Provider Cases), alleged generally that the Company and other defendant managed care organizations engaged in coercive behavior or a
variety of improper business practices in dealing with health care providers and conspired with one another
regarding this purported wrongful conduct.
Page 12
Effective May 21, 2003, the Company and representatives of over 900,000 physicians, state and
other medical societies entered into an agreement (the Physician Settlement Agreement) settling
the lead physician Provider Case, which was pending in the United States District Court for the
Southern District of Florida (the Florida Federal Court). The Company believes that the
Physician Settlement Agreement, which has received final court approval, resolves all pending
Provider Cases filed on behalf of physicians that did not opt out of the settlement. During the
second quarter of 2003, the Company recorded a charge of $75 million ($115 million pretax)
(included in other operating expenses) in connection with the Physician Settlement Agreement, net
of an estimated insurance recoverable of $72 million pretax. The Company has not received any
insurance recoveries as of September 30, 2005.
Several Provider Cases filed in 2003 on behalf of purported classes of chiropractors and/or all
non-physician health care providers also make factual and legal allegations similar to those
contained in the other Provider Cases, including allegations of violations of the Racketeer
Influenced and Corrupt Organizations Act. These Provider Cases have been transferred to the
Florida Federal Court for consolidated pretrial proceedings. The Company intends to defend each
of these cases vigorously.
Securities Class Action Litigation
Laborers Tri-County Pension Fund, Goldplate Investment Partners Ltd. and Sheila Shafran filed a
consolidated and amended purported class action complaint (the Securities Complaint) on June 7,
2002 in the United States District Court for the Southern District of New York (the New York
Federal Court). The Securities Complaint supplanted several complaints, filed beginning November
6, 2001, which were voluntarily dismissed or consolidated. Plaintiffs contended that the Company
and two of its current or former officers and directors, William H. Donaldson and John W. Rowe,
M.D., violated federal securities laws. Plaintiffs alleged misrepresentations and omissions
regarding, among other things, the Companys ability to manage and control medical costs and the
appropriate reserve for medical costs as of December 31, 2000, for which they sought unspecified
damages, among other remedies.
Effective February 2005, the parties agreed to dismiss Mr. Donaldson and Dr. Rowe from the action,
and the Company and class representatives entered into an agreement (the Securities Settlement
Agreement) to settle the Securities Complaint. The New York Federal Court approved the
Securities Settlement Agreement on September 12, 2005. The settlement amount was not material to
the Company.
Insurance Industry Brokerage Practices Matters
The Company has received subpoenas and other requests for information from the New York Attorney
General, the Connecticut Attorney General, other attorneys general and various insurance
regulators with respect to an industry wide investigation into certain insurance brokerage
practices, including broker compensation arrangements, bid quoting practices and potential
antitrust violations. The Company may receive additional subpoenas and requests for information
from these attorneys general and regulators. The Company is cooperating with these inquiries.
In connection with this industry wide review, the Company may receive additional subpoenas and
requests for information from other attorneys general and other regulators, and the Company could
be named in related litigation.
Other Litigation and Regulatory Proceedings
The Company is involved in numerous other lawsuits arising, for the most part, in the ordinary
course of its business operations, including employment litigation and claims of bad faith,
medical malpractice, non-compliance with state regulatory regimes, marketing misconduct, failure
to timely pay medical claims, investment activities, intellectual property and other litigation in
its Health Care and Group Insurance businesses. Some of these other lawsuits are or are purported
to be class actions. The Company intends to defend these matters vigorously.
Page 13
In addition, the Companys current and past business practices are subject to review by, and the
Company from time to time receives subpoenas and other requests for information from, various
state insurance and health care regulatory authorities and other state and federal authorities.
There also continues to be heightened review by regulatory authorities of the managed health care
industrys business practices, including utilization management, delegated arrangements and claim
payment practices. As a leading national managed care organization, the Company regularly is the
subject of such reviews. These reviews may result in changes to or clarifications of the
Companys business practices, and may result in fines, penalties or other sanctions.
The Company is unable to predict at this time the ultimate outcome of the remaining Provider
Cases, the insurance industry brokerage practices investigations or other litigation and
regulatory proceedings, and it is reasonably possible that their outcome could be material to the
Company.
14. Segment Information
Summarized financial information for the Companys principal operations for the three months ended
September 30, 2005 and 2004 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Health |
|
|
Group |
|
|
Large Case |
|
|
Corporate |
|
|
Discontinued |
|
|
Total |
|
(Millions) |
|
Care |
|
|
Insurance |
|
|
Pensions |
|
|
Interest |
|
|
Operations |
|
|
Company |
|
|
Three months ended September 30, 2005 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue from external customers |
|
$ |
4,907.3 |
|
|
$ |
445.9 |
|
|
$ |
59.1 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
5,412.3 |
|
Net investment income |
|
|
76.9 |
|
|
|
78.8 |
|
|
|
124.2 |
|
|
|
|
|
|
|
|
|
|
|
279.9 |
|
|
Total revenue excluding net realized
capital gains |
|
$ |
4,984.2 |
|
|
$ |
524.7 |
|
|
$ |
183.3 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
5,692.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings (loss) (1) |
|
$ |
351.3 |
|
|
$ |
32.5 |
|
|
$ |
9.6 |
|
|
$ |
(21.1 |
) |
|
$ |
|
|
|
$ |
372.3 |
|
Net realized capital gains, net of tax |
|
|
1.2 |
|
|
|
3.3 |
|
|
|
1.0 |
|
|
|
|
|
|
|
|
|
|
|
5.5 |
|
|
Net income (loss) |
|
$ |
352.5 |
|
|
$ |
35.8 |
|
|
$ |
10.6 |
|
|
$ |
(21.1 |
) |
|
$ |
|
|
|
$ |
377.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended September 30, 2004 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue from external customers |
|
$ |
4,292.2 |
|
|
$ |
423.0 |
|
|
$ |
50.8 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
4,766.0 |
|
Net investment income |
|
|
64.3 |
|
|
|
63.7 |
|
|
|
125.9 |
|
|
|
|
|
|
|
|
|
|
|
253.9 |
|
|
Total revenue excluding net realized
capital gains |
|
$ |
4,356.5 |
|
|
$ |
486.7 |
|
|
$ |
176.7 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
5,019.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings (loss) (1) |
|
$ |
268.1 |
|
|
$ |
30.5 |
|
|
$ |
7.7 |
|
|
$ |
(16.8 |
) |
|
$ |
|
|
|
$ |
289.5 |
|
Net realized capital gains, net of tax |
|
|
7.0 |
|
|
|
3.6 |
|
|
|
2.2 |
|
|
|
|
|
|
|
|
|
|
|
12.8 |
|
|
Income (loss) from continuing operations |
|
|
275.1 |
|
|
|
34.1 |
|
|
|
9.9 |
|
|
|
(16.8 |
) |
|
|
|
|
|
|
302.3 |
|
Income from discontinued operations,
net of tax (2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
990.0 |
|
|
|
990.0 |
|
|
Net income (loss) |
|
$ |
275.1 |
|
|
$ |
34.1 |
|
|
$ |
9.9 |
|
|
$ |
(16.8 |
) |
|
$ |
990.0 |
|
|
$ |
1,292.3 |
|
|
|
|
|
(1) |
|
Operating earnings (loss) from continuing operations is
comprised of income (loss) from continuing operations
excluding net realized capital gains. While operating
earnings (loss) is the measure of profit or loss used by
the Companys management when assessing performance or
making operating decisions, it does not replace net income
(loss) as a measure of profitability. |
(2) |
|
Income from discontinued operations of $990.0 million for
the three months ended September 30, 2004 reflects the
completion of certain Internal Revenue Service audits
associated with businesses previously sold (refer to Note
16 for additional information). |
Page 14
Summarized financial information for the Companys principal operations for the nine months
ended September 30, 2005 and 2004 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Health |
|
|
Group |
|
|
Large Case |
|
|
Corporate |
|
|
Discontinued |
|
|
Total |
|
(Millions) |
|
Care |
|
|
Insurance |
|
|
Pensions |
|
|
Interest |
|
|
Operations |
|
|
Company |
|
|
Nine months ended September 30, 2005 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue from external customers |
|
$ |
14,251.0 |
|
|
$ |
1,361.0 |
|
|
$ |
166.2 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
15,778.2 |
|
Net investment income |
|
|
218.2 |
|
|
|
216.2 |
|
|
|
393.3 |
|
|
|
|
|
|
|
|
|
|
|
827.7 |
|
|
Total revenue excluding net realized
capital gains |
|
$ |
14,469.2 |
|
|
$ |
1,577.2 |
|
|
$ |
559.5 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
16,605.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings (loss) (1) |
|
$ |
1,098.9 |
|
|
$ |
94.5 |
|
|
$ |
21.2 |
|
|
$ |
(58.6 |
) |
|
$ |
|
|
|
$ |
1,156.0 |
|
Other item
(2) |
|
|
|
|
|
|
|
|
|
|
43.4 |
|
|
|
|
|
|
|
|
|
|
|
43.4 |
|
Net realized capital gains, net of tax |
|
|
5.0 |
|
|
|
6.6 |
|
|
|
.5 |
|
|
|
|
|
|
|
|
|
|
|
12.1 |
|
|
Net income (loss) |
|
$ |
1,103.9 |
|
|
$ |
101.1 |
|
|
$ |
65.1 |
|
|
$ |
(58.6 |
) |
|
$ |
|
|
|
$ |
1,211.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine months ended September 30, 2004 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue from external customers |
|
$ |
12,526.8 |
|
|
$ |
1,218.5 |
|
|
$ |
153.4 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
13,898.7 |
|
Net investment income |
|
|
193.9 |
|
|
|
201.0 |
|
|
|
390.7 |
|
|
|
|
|
|
|
|
|
|
|
785.6 |
|
|
Total revenue excluding net realized
capital gains |
|
$ |
12,720.7 |
|
|
$ |
1,419.5 |
|
|
$ |
544.1 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
14,684.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings (loss) (1) |
|
$ |
820.5 |
|
|
$ |
88.5 |
|
|
$ |
21.7 |
|
|
$ |
(49.8 |
) |
|
$ |
|
|
|
$ |
880.9 |
|
Net realized capital gains, net of tax |
|
|
12.7 |
|
|
|
13.8 |
|
|
|
7.0 |
|
|
|
|
|
|
|
|
|
|
|
33.5 |
|
|
Income (loss) from continuing operations |
|
|
833.2 |
|
|
|
102.3 |
|
|
|
28.7 |
|
|
|
(49.8 |
) |
|
|
|
|
|
|
914.4 |
|
Discontinued operations, net of taxes (3) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,030.0 |
|
|
|
1,030.0 |
|
|
Net income (loss) |
|
$ |
833.2 |
|
|
$ |
102.3 |
|
|
$ |
28.7 |
|
|
$ |
(49.8 |
) |
|
$ |
1,030.0 |
|
|
$ |
1,944.4 |
|
|
|
|
|
(1) |
|
Operating earnings (loss) from continuing operations is
comprised of income (loss) from continuing operations
excluding net realized capital gains and the other item
(see (2) below). While operating earnings
(loss) is the measure of profit or loss used by the
Companys management when assessing performance or making
operating decisions, it does not replace net income (loss)
as a measure of profitability. |
(2) |
|
The other item excluded from operating earnings (loss) for
the nine months ended September 30, 2005 consists of $43
million after tax ($67 million pretax) from a reduction of
the reserve for anticipated future losses on discontinued
products in the Large Case Pensions segment. There was no
such reduction for the nine months ended September 30,
2004. |
(3) |
|
Income from discontinued operations of $1.03 billion for
the nine months ended September 30, 2004 reflects the
completion of certain Internal Revenue Service audits
associated with businesses previously sold (refer to Note
16 for additional information). |
15. Discontinued Products
The Company discontinued the sale of its fully guaranteed large case pension products
(single-premium annuities (SPAs) and guaranteed investment contracts (GICs)) in 1993. Under
the Companys accounting for these discontinued products, a reserve for anticipated future losses
from these products was established and is reviewed by management quarterly. As long as the
reserve continues to represent managements then best estimate of expected future losses, results
of operations of the discontinued products, including net realized capital gains and losses, are
credited/charged to the reserve and do not affect the Companys results of operations. The
Companys results of operations would be adversely affected to the extent that future losses on the
products are greater than anticipated and favorably affected to the extent that future losses are
less than anticipated. The current reserve reflects managements best estimate of anticipated
future losses.
The factors contributing to changes in the reserve for anticipated future losses are: operating
income or loss, realized capital gains or losses and mortality gains or losses. Operating income
or loss is equal to revenue less expenses. Realized capital gains or losses reflect the excess
(deficit) of sales price over (below) the carrying value of assets sold and any
other-than-temporary impairments. Mortality gains or losses reflect the mortality and retirement
experience related to SPAs. A mortality gain (loss) occurs when an annuitant or a beneficiary
dies sooner (later) than expected. A retirement gain (loss) occurs when an annuitant retires
later (earlier) than expected.
Page 15
At the time of discontinuance, a receivable from Large Case Pensions continuing products
equivalent to the net present value of the anticipated cash flow shortfalls was established for the
discontinued products. Interest on the receivable is accrued at the discount rate that was used to
calculate the reserve. The offsetting payable, on which interest is similarly accrued, is reflected
in continuing products. Interest on the payable generally offsets the investment income on the
assets available to fund the shortfall. At September 30, 2005, the receivable from continuing
products, net of related deferred taxes payable of $125 million on the accrued interest income, was
$367 million. At December 31, 2004, the receivable from continuing products, net of related
deferred taxes payable of $116 million on accrued interest income, was $395 million. These amounts
were eliminated in consolidation.
Results of discontinued products for the three and nine months ended September 30, 2005 and 2004
were as follows (pretax):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Charged (Credited) |
|
|
|
|
|
|
|
|
|
|
to Reserve for |
|
|
|
|
(Millions) |
|
Results |
|
|
Future Losses |
|
|
Net (1) |
|
|
Three months ended September 30, 2005 |
|
|
|
|
|
|
|
|
|
|
|
|
Net investment income |
|
$ |
72.3 |
|
|
$ |
|
|
|
$ |
72.3 |
|
Net realized capital gains |
|
|
12.3 |
|
|
|
(12.3 |
) |
|
|
|
|
Interest earned on receivable from continuing products |
|
|
7.4 |
|
|
|
|
|
|
|
7.4 |
|
Other revenue |
|
|
3.8 |
|
|
|
|
|
|
|
3.8 |
|
|
Total revenue |
|
|
95.8 |
|
|
|
(12.3 |
) |
|
|
83.5 |
|
|
Current and future benefits |
|
|
85.2 |
|
|
|
(5.1 |
) |
|
|
80.1 |
|
Operating expenses |
|
|
3.4 |
|
|
|
|
|
|
|
3.4 |
|
|
Total benefits and expenses |
|
|
88.6 |
|
|
|
(5.1 |
) |
|
|
83.5 |
|
|
Results of discontinued products |
|
$ |
7.2 |
|
|
$ |
(7.2 |
) |
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended September 30, 2004 |
|
|
|
|
|
|
|
|
|
|
|
|
Net investment income |
|
$ |
75.3 |
|
|
$ |
|
|
|
$ |
75.3 |
|
Net realized capital gains |
|
|
6.7 |
|
|
|
(6.7 |
) |
|
|
|
|
Interest earned on receivable from continuing products |
|
|
7.6 |
|
|
|
|
|
|
|
7.6 |
|
Other revenue |
|
|
5.8 |
|
|
|
|
|
|
|
5.8 |
|
|
Total revenue |
|
|
95.4 |
|
|
|
(6.7 |
) |
|
|
88.7 |
|
|
Current and future benefits |
|
|
88.6 |
|
|
|
(3.2 |
) |
|
|
85.4 |
|
Operating expenses |
|
|
3.3 |
|
|
|
|
|
|
|
3.3 |
|
|
Total benefits and expenses |
|
|
91.9 |
|
|
|
(3.2 |
) |
|
|
88.7 |
|
|
Results of discontinued products |
|
$ |
3.5 |
|
|
$ |
(3.5 |
) |
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine months ended September 30, 2005 |
|
|
|
|
|
|
|
|
|
|
|
|
Net investment income |
|
$ |
248.0 |
|
|
$ |
|
|
|
$ |
248.0 |
|
Net realized capital gains |
|
|
12.2 |
|
|
|
(12.2 |
) |
|
|
|
|
Interest earned on receivable from continuing products |
|
|
23.1 |
|
|
|
|
|
|
|
23.1 |
|
Other revenue |
|
|
16.3 |
|
|
|
|
|
|
|
16.3 |
|
|
Total revenue |
|
|
299.6 |
|
|
|
(12.2 |
) |
|
|
287.4 |
|
|
Current and future benefits |
|
|
258.2 |
|
|
|
21.1 |
|
|
|
279.3 |
|
Operating expenses |
|
|
8.1 |
|
|
|
|
|
|
|
8.1 |
|
|
Total benefits and expenses |
|
|
266.3 |
|
|
|
21.1 |
|
|
|
287.4 |
|
|
Results of discontinued products |
|
$ |
33.3 |
|
|
$ |
(33.3 |
) |
|
$ |
|
|
|
|
Nine months ended September 30, 2004 |
|
|
|
|
|
|
|
|
|
|
|
|
Net investment income |
|
$ |
235.8 |
|
|
$ |
|
|
|
$ |
235.8 |
|
Net realized capital gains |
|
|
21.0 |
|
|
|
(21.0 |
) |
|
|
|
|
Interest earned on receivable from continuing products |
|
|
22.5 |
|
|
|
|
|
|
|
22.5 |
|
Other revenue |
|
|
20.4 |
|
|
|
|
|
|
|
20.4 |
|
|
Total revenue |
|
|
299.7 |
|
|
|
(21.0 |
) |
|
|
278.7 |
|
|
Current and future benefits |
|
|
268.4 |
|
|
|
.5 |
|
|
|
268.9 |
|
Operating expenses |
|
|
9.8 |
|
|
|
|
|
|
|
9.8 |
|
|
Total benefits and expenses |
|
|
278.2 |
|
|
|
.5 |
|
|
|
278.7 |
|
|
Results of discontinued products |
|
$ |
21.5 |
|
|
$ |
(21.5 |
) |
|
$ |
|
|
|
|
|
|
(1) |
|
Amounts are reflected in the September 30, 2005 and 2004
Consolidated Statements of Income, except for interest
earned on the receivable from continuing products, which was
eliminated in consolidation. |
Page 16
Assets and liabilities supporting discontinued products at September 30, 2005 and December 31,
2004 were as follows: (1)
|
|
|
|
|
|
|
|
|
|
|
September 30, |
|
|
December 31, |
|
(Millions) |
|
2005 |
|
|
2004 |
|
|
Assets: |
|
|
|
|
|
|
|
|
Debt securities available for sale |
|
$ |
3,134.6 |
|
|
$ |
3,383.6 |
|
Equity securities available for sale |
|
|
52.9 |
|
|
|
57.2 |
|
Mortgage loans |
|
|
607.2 |
|
|
|
560.3 |
|
Investment real estate |
|
|
110.2 |
|
|
|
114.8 |
|
Loaned securities |
|
|
327.9 |
|
|
|
322.8 |
|
Other investments (2) |
|
|
545.9 |
|
|
|
514.4 |
|
|
Total investments |
|
|
4,778.7 |
|
|
|
4,953.1 |
|
Collateral received under securities loan agreements |
|
|
334.7 |
|
|
|
329.6 |
|
Current and deferred income taxes |
|
|
104.4 |
|
|
|
120.8 |
|
Receivable from continuing products (3) |
|
|
491.3 |
|
|
|
511.6 |
|
|
Total assets |
|
$ |
5,709.1 |
|
|
$ |
5,915.1 |
|
|
Liabilities: |
|
|
|
|
|
|
|
|
Future policy benefits |
|
$ |
3,944.0 |
|
|
$ |
4,065.6 |
|
Policyholders funds |
|
|
24.8 |
|
|
|
24.0 |
|
Reserve for anticipated future losses on discontinued products |
|
|
1,046.4 |
|
|
|
1,079.8 |
|
Collateral payable under securities loan agreements |
|
|
334.7 |
|
|
|
329.6 |
|
Other liabilities |
|
|
359.2 |
|
|
|
416.1 |
|
|
Total liabilities |
|
$ |
5,709.1 |
|
|
$ |
5,915.1 |
|
|
|
|
|
(1) |
|
Assets supporting the discontinued products are distinguished from assets supporting continuing products. |
(2) |
|
Includes debt securities on deposit as required by regulatory authorities of $21.3 million and $20.9
million at September 30, 2005 and December 31, 2004, respectively. These securities are considered
restricted assets and were included in long-term investments on the Consolidated Balance Sheets. |
(3) |
|
The receivable from continuing products is eliminated in consolidation. |
At September 30, 2005 and December 31, 2004, net unrealized capital gains on available for
sale debt securities are included above in other liabilities and are not reflected in consolidated
shareholders equity. The reserve for anticipated future losses is included in future policy
benefits on the Consolidated Balance Sheets.
The reserve for anticipated future losses on discontinued products represents the present value (at
a risk-free rate of return at the time of discontinuance, consistent with the duration of the
liabilities) of the difference between the expected cash flows from the assets supporting
discontinued products and the cash flows expected to be required to meet the obligations of the
outstanding contracts. Calculation of the reserve for anticipated future losses requires
projection of both the amount and the timing of cash flows over approximately the next 30 years,
including consideration of, among other things, future investment results, participant withdrawal
and mortality rates as well as the cost of asset management and customer service. Since 1993,
there have been no significant changes to the assumptions underlying the calculation of the reserve
related to the projection of the amount and timing of cash flows.
The projection of future investment results considers assumptions for interest rates, bond
discount rates and performance of mortgage loans and real estate. Mortgage loan cash flow
assumptions represent managements best estimate of current and future levels of rent growth,
vacancy and expenses based upon market conditions at each reporting date. The performance of real
estate assets has been consistently estimated using the most recent forecasts available. Since
1997, a bond default assumption has been included to reflect historical default experience, since
the bond portfolio increased as a percentage of the overall investment portfolio and reflected
more bond credit risk, concurrent with the declines in the commercial mortgage loan and real
estate portfolios.
The previous years actual participant withdrawal experience is used for the current year
assumption. Prior to 1995, the Company used the 1983 Group Annuitant Mortality table published by
the Society of Actuaries (the Society). In 1995, the Society published the 1994 Uninsured Pensioners Mortality table, which
the Company has used since then.
Page 17
The Companys assumptions about the cost of asset management and customer service reflect
actual investment and general expenses allocated over invested assets.
The activity in the reserve for anticipated future losses on discontinued products for the nine
months ended September 30, 2005 was as follows (pretax):
|
|
|
|
|
(Millions) |
|
|
|
|
|
Reserve for anticipated future losses on discontinued products at December 31, 2004 |
|
$ |
1,079.8 |
|
Operating income |
|
|
13.6 |
|
Net realized capital gains |
|
|
12.2 |
|
Mortality and other |
|
|
7.5 |
|
Reserve reduction |
|
|
(66.7 |
) |
|
Reserve for anticipated future losses on discontinued products at September 30, 2005 |
|
$ |
1,046.4 |
|
|
Management reviews the adequacy of the discontinued products reserve quarterly and, as a
result, $67 million ($43 million after tax) of the reserve
was released in the nine months ended September 30, 2005, primarily due to favorable investment performance and favorable mortality and retirement
experience compared to prior assumptions.
16. Discontinued Operations
Discontinued operations of $990 million and $1.03 billion for the three and nine months ended
September 30, 2004, respectively, reflects the completion of certain Internal Revenue Service
audits associated with businesses previously sold.
Page 18
Report of Independent Registered Public Accounting Firm
The Board of Directors and Shareholders
Aetna Inc.:
We have reviewed the consolidated balance sheet of Aetna Inc. and subsidiaries as of September 30,
2005, the related consolidated statements of income for the three-month and nine-month periods
ended September 30, 2005 and 2004, and the related consolidated statements of shareholders equity
and cash flows for the nine-month periods ended September 30, 2005 and 2004. These condensed
consolidated financial statements are the responsibility of the Companys management.
We conducted our reviews in accordance with the standards of the Public Company Accounting
Oversight Board (United States). A review of interim financial information consists principally of
applying analytical procedures and making inquiries of persons responsible for financial and
accounting matters. It is substantially less in scope than an audit conducted in accordance with
the standards of the Public Company Accounting Oversight Board (United States), the objective of
which is the expression of an opinion regarding the financial statements taken as a whole.
Accordingly, we do not express such an opinion.
Based on our reviews, we are not aware of any material modifications that should be made to the
condensed consolidated financial statements referred to above for them to be in conformity with
U.S. generally accepted accounting principles.
We have previously audited, in accordance with standards of the Public Company Accounting Oversight
Board (United States), the consolidated balance sheet of Aetna Inc. and subsidiaries as of December
31, 2004, and the related consolidated statements of income, shareholders equity and cash flows
for the year then ended (not presented herein); and in our report dated March 1, 2005, we expressed
an unqualified opinion on those consolidated financial statements. In our opinion, the information
set forth in the accompanying consolidated balance sheet as of December 31, 2004, is fairly stated,
in all material respects, in relation to the consolidated balance sheet from which it has been
derived.
/s/ KPMG LLP
Hartford, Connecticut
October 26, 2005
Page 19
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (MD&A)
Unless the context otherwise requires, references to the terms we, our, or us used throughout
this MD&A, refer to Aetna Inc. (Aetna) and its subsidiaries (collectively, the Company).
OVERVIEW
We are one of the nations largest providers of health insurance and related benefits, based on
membership as of September 30, 2005. Our products include medical, dental, pharmacy and group
insurance (including life, disability and long-term care) benefit products. As of September 30,
2005, we served approximately 14.7 million medical members, 13.0 million dental members, 9.3
million pharmacy members and 13.7 million group insurance members. Our operations are conducted in
three business segments: Health Care, Group Insurance and Large Case Pensions.
The following MD&A provides a review of our financial condition as of September 30, 2005 and
December 31, 2004 and results of operations for the three and nine months ended September 30, 2005
and 2004. This Overview should be read in conjunction with the entire MD&A, which contains
detailed information that is important to understanding our results of operations and financial
condition and the consolidated financial statements and other data presented herein as well as the
MD&A contained in our 2004 Annual Report on Form 10-K (the 2004 Annual Report). This Overview is
qualified in its entirety by the full MD&A below.
Our operating profit for the three and nine months ended September 30, 2005, compared to the
corresponding periods in 2004, reflects continued growth in our Health Care business, excluding
favorable development of prior period health care cost estimates. This primarily reflects growth
in revenues from higher membership levels and strong underwriting results (including increases in
per member premiums which slightly outpaced per member increases in health care costs), as well as
continued improvement in general and administrative expense efficiencies (the ratio of these
expenses to our total revenue). We experienced membership growth for both administrative services
contract (ASC) business (an employer-funded plan where the plan sponsor assumes all or a majority
of the risk for medical and dental care costs) and Risk business (where we assume all or a majority
of the risk for medical and dental care costs), including approximately 170,000 Risk members
associated with the acquisition of Strategic Resource Company (SRC), which closed in the first
quarter of 2005. Our medical membership was 14.7 million members at September 30, 2005,
representing approximately 35% Risk members and 65% ASC members. We continue to take actions
designed to achieve membership levels at December 31, 2005 of approximately 1,000,000 to 1,075,000
members higher than at December 31, 2004.
We continued to generate cash from operations for the nine months ended September 30, 2005. In
addition to funding ordinary course operating activities, approximately $150 million of cash was
used to pay a prior year physician class action settlement and $245 million of cash was used to
make a voluntary contribution to our pension plan. Additional uses from available cash for the
nine months ended September 30, 2005 included $1.2 billion, used to repurchase our common stock
under our share repurchase programs and $1.0 billion, used for acquisitions (see below and also
refer to Note 3 of Condensed Notes to Consolidated Financial Statements).
Page 20
Summary of Consolidated Results for the Three and Nine Months Ended September 30, 2005 and 2004:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
September 30, |
|
|
September 30, |
(Millions, except per share amounts) |
|
2005 |
|
|
2004 |
|
|
2005 |
|
|
2004 |
|
|
Total revenues |
|
$ |
5,700.7 |
|
|
$ |
5,039.5 |
|
|
$ |
16,624.5 |
|
|
$ |
14,735.8 |
|
|
Income from continuing operations (1) |
|
|
377.8 |
|
|
|
302.3 |
|
|
|
1,211.5 |
|
|
|
914.4 |
|
|
Net income (2) |
|
|
377.8 |
|
|
|
1,292.3 |
|
|
|
1,211.5 |
|
|
|
1,944.4 |
|
|
Income from continuing operations per common share |
|
|
1.26 |
|
|
|
.96 |
|
|
|
4.01 |
|
|
|
2.88 |
|
|
Net income per common share |
|
|
1.26 |
|
|
|
4.10 |
|
|
|
4.01 |
|
|
|
6.13 |
|
|
|
|
|
(1) |
|
Income from continuing operations for the three months
ended September 30, 2005 and 2004 reflects favorable
development of prior period health care cost estimates
of approximately $15 million ($24 million pretax) and
$14 million ($22 million pretax), respectively, in the
Health Care segment. Income from continuing operations
for the nine months ended September 30, 2005 reflects
the release of approximately $65 million ($103 million
pretax) of reserves related to the New York Market
Stabilization Pool (refer to Note 13 of Condensed Notes
to Consolidated Financial Statements) and a reduction of
the reserve for anticipated future losses on
discontinued products in the Large Case Pensions segment
of $43 million ($67 million pretax). |
(2) |
|
Net income for the three months ended September 30, 2005
and 2004 includes net realized capital gains of $6
million and $13 million, respectively, and the nine
months ended September 30, 2005 and 2004 includes net
realized capital gains of $12 million and $34 million,
respectively. Net income for the three and nine months
ended September 30, 2004 includes income from
discontinued operations of $990 million and $1.03
billion, respectively, related to the completion of
certain Internal Revenue Service audits associated with
businesses previously sold. |
Business Development Transactions
In January 2005, we acquired Strategic Resource Company (SRC), a privately held administrator of
group limited benefit products for part-time and hourly workers. For approximately $252 million,
financed through available cash, we acquired 100% of the stock of SRC and reinsured the insurance
contracts administered by SRC. Approximately $67 million of the purchase price is currently held
in escrow pending resolution of certain future events. We recorded approximately $82 million of
intangible assets (primarily customer lists) and approximately $128 million of goodwill, which
represents the purchase price in excess of the fair value of the net assets acquired.
In May 2005, we acquired Active Health Management, Inc. (Active Health), a privately held health
management and health care data analytics company, for approximately $405 million, financed
through available cash. We preliminarily recorded approximately $89 million of intangible assets (primarily
customer lists, technology and trademarks) and goodwill of approximately $311 million, which
represents the purchase price in excess of the fair value of the net assets acquired.
In July 2005, we acquired HMS Healthcare, Inc. (HMS), a privately held regional health care
network, primarily in Michigan and Colorado, for approximately $390 million, financed through
available cash. In the third quarter of 2005, we preliminarily recorded approximately $176
million of intangible assets (primarily customer lists and tradenames) and goodwill of
approximately $240 million, which represents the purchase price in excess of the fair value of the
net assets acquired.
The intangible assets and goodwill related to the acquisitions of Active Health and HMS are
subject to adjustment upon completion of purchase accounting valuations.
In
October 2005, we announced our intention to exercise our
option to purchase the remaining 60% ownership interest in Aetna
Speciality Pharmacy, LLC (ASP) from our venture partner,
Priority Healthcare Corporation. As a result of this purchase, which is subject to federal antitrust regulatory approval, we would own 100% of ASP. The
purchase price is not material to us. Refer to Note 3 to the
consolidated financial statements presented in the 2004 Annual Report
for additional information.
Management Update
Effective September 6, 2005, William J. Casazza was named Senior Vice President and General
Counsel, reporting to Chairman and Chief Executive Officer, John W.
Rowe, M.D. Mr. Casazza
succeeds Louis J. Briskman, who resigned in the third quarter of 2005. Mr. Casazza now serves as a
member of the Office of the Chairman, our most senior management group.
William C. Popik, M.D., Chief Medical Officer and Head of National Medical Services, retired on
September 30, 2005. Charles M. Cutler, M.D. is serving as interim Chief Medical Officer, reporting
to President Ronald A. Williams. Dr. Cutler is currently our National Medical Director for
Quality.
Page 21
Addition to the Board of Directors
Effective October 1, 2005, Molly J. Coye, M.D., founder and CEO of the Health Technology Center,
was appointed to our Board of Directors (the Board). With the addition of Dr. Coye, the Board
expands to 12 members. Dr. Coye also will serve as a member of the Boards Medical Affairs
Committee.
Discussion of Segment Results
The discussion of our results of operations that follows is presented based on our reportable
segments in accordance with Financial Accounting Standard (FAS) No. 131, Disclosures about
Segments of an Enterprise and Related Information, and is consistent with the disclosure of segment
information in Note 14 of Condensed Notes to Consolidated Financial Statements. The measure of
profit or loss presented within each segments discussion of results of operations is the measure
reported to our Chief Executive Officer for purposes of making decisions about allocating resources
to the segment and assessing its performance.
HEALTH CARE
Health Care consists of medical and dental plans offered on both a Risk basis and an
employer-funded basis. Medical plans include point-of-service (POS), health maintenance
organization (HMO), preferred provider organization (PPO) and indemnity benefit (Indemnity)
products. Health plans also include health savings accounts (HSAs) and Aetna
HealthFund®, consumer-directed health plans that combine traditional POS, PPO and/or
dental coverage, subject to a deductible, with an accumulating benefit account.
Operating Summary for the Three and Nine Months Ended September 30, 2005 and 2004:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
September 30, |
|
|
September 30, |
(Millions) |
|
2005 |
|
|
2004 |
|
|
2005 |
|
|
2004 |
|
|
Premiums: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commerical Risk (1) |
|
$ |
4,039.3 |
|
|
$ |
3,545.7 |
|
|
$ |
11,742.0 |
|
|
$ |
10,282.9 |
|
Medicare |
|
|
252.0 |
|
|
|
240.9 |
|
|
|
748.5 |
|
|
|
709.5 |
|
|
Total premiums |
|
|
4,291.3 |
|
|
|
3,786.6 |
|
|
|
12,490.5 |
|
|
|
10,992.4 |
|
|
Administrative services contract fees |
|
|
576.1 |
|
|
|
500.6 |
|
|
|
1,702.7 |
|
|
|
1,516.4 |
|
Net investment income |
|
|
76.9 |
|
|
|
64.3 |
|
|
|
218.2 |
|
|
|
193.9 |
|
Other revenue |
|
|
39.9 |
|
|
|
5.0 |
|
|
|
57.8 |
|
|
|
18.0 |
|
Net realized capital gains |
|
|
1.9 |
|
|
|
10.7 |
|
|
|
7.7 |
|
|
|
19.4 |
|
|
Total revenue |
|
|
4,986.1 |
|
|
|
4,367.2 |
|
|
|
14,476.9 |
|
|
|
12,740.1 |
|
|
Health care costs (2) |
|
|
3,390.4 |
|
|
|
2,994.3 |
|
|
|
9,683.6 |
|
|
|
8,611.2 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling expenses |
|
|
193.5 |
|
|
|
161.0 |
|
|
|
562.5 |
|
|
|
463.6 |
|
General and administrative expenses (3) |
|
|
830.8 |
|
|
|
767.3 |
|
|
|
2,453.5 |
|
|
|
2,311.8 |
|
Amortization of other acquired intangible assets |
|
|
15.9 |
|
|
|
9.3 |
|
|
|
38.1 |
|
|
|
34.7 |
|
|
Total benefits and expenses |
|
|
4,430.6 |
|
|
|
3,931.9 |
|
|
|
12,737.7 |
|
|
|
11,421.3 |
|
|
Income before income taxes |
|
|
555.5 |
|
|
|
435.3 |
|
|
|
1,739.2 |
|
|
|
1,318.8 |
|
Income taxes |
|
|
203.0 |
|
|
|
160.2 |
|
|
|
635.3 |
|
|
|
485.6 |
|
|
Net income |
|
$ |
352.5 |
|
|
$ |
275.1 |
|
|
$ |
1,103.9 |
|
|
$ |
833.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net realized capital gains, net of tax (included above) |
|
$ |
1.2 |
|
|
$ |
7.0 |
|
|
$ |
5.0 |
|
|
$ |
12.7 |
|
|
|
|
|
(1) |
|
Commercial Risk includes all medical and dental risk products, except Medicare and Medicaid. |
(2) |
|
The percentage of health care costs related to capitated arrangements (a fee arrangement
where the Company pays providers a monthly fixed fee for each member, regardless of the
medical services provided to the member) was 7.8% and 8.1% for the three and nine months
ended September 30, 2005, respectively, compared to 8.7% and 9.2%, respectively, for the
corresponding periods in 2004. |
(3) |
|
Includes salaries and related benefit expenses of $504.1 million and $1.5 billion for the
three and nine months ended September 30, 2005, respectively, and $473.1 million and $1.4
billion, respectively, for the corresponding periods in 2004. |
Health Care Results
The table presented below reconciles operating earnings to net income reported in accordance with
U.S. generally accepted accounting principles (GAAP) for the three and nine months ended
September 30, 2005 and 2004. Operating earnings exclude realized capital gains and losses. We
believe excluding realized capital gains and losses to arrive at operating earnings provides more
useful information as to our underlying business performance. Realized
capital gains and losses arise from various types of transactions
primarily in the course of managing a portfolio of assets that
support the payment of liabilities, but these transactions do not
directly relate to the underwriting or servicing of products for
customers and are not directly related to the core performance or our
business operations. In addition, management uses operating earnings
to assess performance and make operating decisions.
Page 22
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
September 30, |
|
|
September 30, |
(Millions) |
|
2005 |
|
|
2004 |
|
|
2005 |
|
|
2004 |
|
|
Net income |
|
$ |
352.5 |
|
|
$ |
275.1 |
|
|
$ |
1,103.9 |
|
|
$ |
833.2 |
|
Net realized capital gains |
|
|
(1.2 |
) |
|
|
(7.0 |
) |
|
|
(5.0 |
) |
|
|
(12.7 |
) |
|
Operating earnings |
|
$ |
351.3 |
|
|
$ |
268.1 |
|
|
$ |
1,098.9 |
|
|
$ |
820.5 |
|
|
Results for the three and nine months ended September 30, 2005 reflect growth from the corresponding periods in 2004
The increase in operating earnings for the three and nine months
ended September 30, 2005, when
compared to the corresponding periods in 2004, reflects higher total underwriting margins (premiums
less health care costs), ASC fees, other revenue and net investment income as well as improved
operating expense efficiencies. The total underwriting margin reflects growth in premiums and a
lower Commercial Risk medical cost ratio as further discussed below. The growth in premiums and
ASC fees resulted from rate increases for renewing membership as well as increases in membership
levels (refer to Membership below), including approximately 170,000 Risk members associated with
the acquisition of SRC. Other revenue reflects growth resulting from our recent acquisitions of
Active Health and HMS. Net investment income increased due to higher yields from debt securities,
as well as higher limited partnership income and mortgage prepayment fees.
We continued to gain operating expense efficiencies as a percentage of revenue. However, total
operating expenses increased in the 2005 periods when compared to 2004 due to expenses related to
the growth in membership and acquisitions. Total selling expenses increased due to higher overall
premiums and a higher proportion of premiums in certain customer markets which have higher selling
costs. General and administrative expenses increased due to higher employee related costs,
facilities and equipment costs and claim services costs, in each case associated with higher
membership. General and administrative expenses for the nine months ended September 30, 2004 also
include a curtailment benefit of $32 million ($21 million after tax) related to the elimination of
the dental subsidy for all retirees.
Our Commercial Risk products continued to grow for the three and nine months ended September 30,
2005
Commercial Risk premiums increased approximately $494 million and $1.5 billion for the three and
nine months ended September 30, 2005, respectively, when compared to the corresponding periods in
2004. These increases reflect an increase in membership levels and premium rate increases on
renewing business.
The Commercial Risk medical cost ratio was 78.6% for both the three months ended September 30, 2005
and 2004. Health care costs for the third quarter of 2005 and 2004 reflect favorable development
of prior period health care cost estimates of approximately $15 million pretax and $20 million
pretax, respectively. The favorable development of prior period health care cost estimates relates
to health care costs incurred in preceding periods and considers the actual claim experience that
emerged in the third quarter of 2005 and 2004, as well as lower than expected health care cost
trends (refer to discussion of Health Care Costs Payable below for more information).
Excluding the favorable development of prior period health care cost estimates, the adjusted
Commercial Risk medical cost ratio was 79.0% for the three months ended September 30, 2005
compared to 79.2% for the corresponding period in 2004 (refer to the reconciliations of Commercial
Risk health care costs to adjusted Commercial Risk health care costs below). This decrease in the
medical cost ratio for the third quarter of 2005 reflects an increase in per member premiums that slightly outpaced increases in per member health
care costs. The increase in per member health care costs were driven
by increases across all medical cost service categories, with higher
increases in outpatient and ancillary services, than in inpatient,
physician and pharmacy services.
Page 23
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
September 30, |
(Millions) |
|
2005 |
|
|
2004 |
|
|
Commercial Risk health care costs (included in total health care costs above) |
|
$ |
3,174.9 |
|
|
$ |
2,786.6 |
|
Approximate favorable development of prior period health care cost estimates |
|
|
15.0 |
|
|
|
20.0 |
|
|
Adjusted Commercial Risk health care costs |
|
$ |
3,189.9 |
|
|
$ |
2,806.6 |
|
|
During the nine months ended September 30, 2005, we, certain other carriers and the New York
State Insurance Department entered into an agreement as to our participation in the New York State
Market Stabilization Pool under New York Regulation 146 (Regulation 146) for the years 1999
through 2004. Regulation 146 requires all carriers with small group and/or individual business in
New York State to participate in a market stabilization pooling mechanism under which carriers that
experience higher than average cost factors in providing services to members with specified medical
conditions receive payments from the pool, and carriers that experience lower than average cost
factors make payments to the pool. From 1999 through 2004, in the absence of any pool data
regarding relative average cost factors of the carriers doing business in New York State, we made
provisions for our estimate of liabilities incurred in this pool based on discussions with the New
York State Insurance Department and historical experience. As of December 31, 2004 we had recorded
reserves (included in health care costs payable) of approximately $89 million based on these
estimates.
In June 2005, we entered into an agreement with the New York State Insurance Department and other
carriers participating in the pool that modified the mechanism by which the amounts due to (or
receivable from) the pool were to be settled. Under this agreement, we were a net receiver of
approximately $14 million in cash from the pool in satisfaction of all our remaining obligations
relating to the pool for the years 1999 through 2004. Accordingly, during the nine months ended
September 30, 2005, we released the $89 million liability recorded as of December 31, 2004,
resulting in a $103 million pretax favorable development of prior period health care costs during
the nine months ended September 30, 2005. This agreement also eliminates any further payment
obligation we have for 2005. The New York State Insurance Department intends to propose a new
pooling mechanism for years subsequent to 2005.
The Commercial Risk medical cost ratio was 76.9% for the nine months ended September 30, 2005,
compared to 77.8% for the corresponding period in 2004. The decrease reflects higher reported
favorable development of prior period health care costs in 2005, compared to 2004, as well as an
increase in per member premiums which outpaced increases in per member health care costs. The increase in per member health care costs were driven
by increases across all medical cost service categories, with higher
increases in outpatient and ancillary services, than in inpatient,
physician and pharmacy services.
Medicare Results
Medicare premiums increased approximately $11 million and $39 million for the three and nine months
ended September 30, 2005, respectively, when compared to the corresponding periods in 2004. This
increase reflects increases in supplemental premiums and rate increases by the Centers for Medicare
and Medicaid Services.
The Medicare medical cost ratio for the three months ended September 30, 2005 was 85.5%, compared
to 86.2% for the corresponding period in 2004. Health care costs for the third quarter of 2005 and
2004 reflect favorable development of prior period health care cost estimates of approximately $9
million pretax and $2 million pretax, respectively. Excluding this favorable development, the
adjusted Medicare medical cost ratio was 89.1% for the three months ended September 30, 2005,
compared to 87.0% for the corresponding period in 2004 (refer to the reconciliations of Medicare
health care costs to adjusted Medicare health care costs below). The increase in the medical cost
ratio for the third quarter of 2005 reflects a rate of increase for per member health care costs
that outpaced the rate of increase for per member premiums, primarily due to higher utilization of
health care services in the third quarter of 2005, compared to the corresponding period in 2004.
Page 24
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
September 30, |
(Millions) |
|
2005 |
|
|
2004 |
|
|
Medicare health care costs (included in total health care costs above) |
|
$ |
215.5 |
|
|
$ |
207.7 |
|
Approximate favorable development of prior period health care cost estimates |
|
|
9.0 |
|
|
|
2.0 |
|
|
Adjusted Medicare health care costs |
|
$ |
224.5 |
|
|
$ |
209.7 |
|
|
The Medicare medical cost ratio was 86.6% for the nine months ended September 30, 2005,
compared to 85.4% for the corresponding period in 2004. The increase reflects a rate of increase
of per member health care costs that outpaced the rate of increase for per member premiums.
Health Care Costs Payable
Health care costs payable reflects estimates of the ultimate cost of claims that have been incurred
but not yet reported and those which have been reported but not yet paid. We develop such
estimates using actuarial principles and assumptions that consider, among other things, historical
and projected claim submission patterns, historical and projected claim processing time, medical
cost trends, utilization of health care services, claim inventory levels, changes in membership and
product mix, seasonality and other relevant factors. In developing our estimate of health care
costs payable, we consistently apply the actuarial principles and assumptions each period, with
consideration to the variability of these factors.
Historical claim payment patterns are analyzed by comparing the claim incurred dates (i.e., the
date the service was provided) to the claim payment dates to determine completion factors. By
aggregating claim data based on the month of service and month of claim payment, we estimate the
percentage of claims incurred for a given month that are complete by each month thereafter, hence
calculating completion factors. For any given month, substantially all claims are paid within six
months of the date of service, but it can take up to 48 months or longer before all of the claims
are completely resolved and paid. These historically derived completion factors are then applied
to claims paid through the financial statement date to estimate the ultimate claim cost for a given
months incurred claim activity. The difference between the estimated ultimate claim cost and the
claims paid through the financial statement date represents our estimate of remaining claims to be
paid as of the financial statement date and is included in our health care costs payable.
Completion factors are used predominantly to estimate reserves for claim activity greater than
three to four months prior to the financial statement date. However, the actual completion factors
used reflect judgments and possible adjustments for such data as claim inventory levels, claim
submission patterns and claim processing rates.
Because claims incurred within three to four months prior to the financial statement date have less
activity (i.e., a large portion of health care claims are not submitted to us until after the end
of the quarter in which services are rendered by providers to members), estimates of the ultimate
claims incurred for these months are not based solely on the historically derived completion
factors. Rather, the estimates for these months also reflect analysis of medical cost trends,
seasonal patterns, changes in membership and product mix, as well as historical and projected claim
submission and processing times.
For all the time periods, an extensive degree of judgment is used in the estimation process, and as
a result, considerable variability is inherent in such estimates, and the adequacy of the estimates
is highly sensitive to changes in medical claims submission and payment patterns (including
completion factors) and changes in medical cost trends.
We believe our estimate of health care costs payable is reasonable and adequate to cover our
obligations as of September 30, 2005; however, actual claim payments may differ from established
estimates. A worsening (or improvement) of medical cost trend (the rate of increase in per member
health care costs) or changes in claim submission and payment patterns from those that were assumed
in estimating health care costs payable at September 30, 2005 would cause these estimates to change
in the near term, and such a change could be material.
Each quarter, we re-examine previously established health care costs payable estimates based on
actual claim payments for prior periods and other changes in facts and circumstances. Given the
extensive degree of judgment in this estimate, it is possible that estimates of health care costs
payable could develop either favorably or
unfavorably. We include the impacts of changes in estimates in earnings when they are identified.
The changes in the estimate of health care costs payable may relate to the prior fiscal quarter,
prior fiscal year or earlier periods.
Page 25
Other
Sources of Revenue
Administrative services contract fees increased approximately $76 million and $186 million for the
three and nine months ended September 30, 2005, respectively, when compared to the corresponding
periods in 2004, reflecting growth in membership, rate increases and sales of add-on services.
Other revenue reflects increases primarily resulting from our acquisitions of Active Health and HMS.
Net realized capital gains for the three months ended September 30, 2005 are due to gains on debt
securities from rebalancing our investment portfolio and recoveries from investments previously
written-down, partially offset by losses from futures contracts used for correlating the maturities
of invested assets with the payment of expected liabilities. Net realized capital gains for the
nine months ended September 30, 2005 are due to gains on debt securities from rebalancing our
investment portfolio and recoveries from investments previously written-down, as well as real
estate gains. Net realized capital gains for the three and nine months ended September 30, 2004
are due primarily to gains on debt securities from sales in a low interest rate environment and the
write-down of other invested assets.
Membership
Health Cares membership at September 30, 2005 and 2004 was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 |
|
|
2004 |
(Thousands) |
|
Risk |
|
|
ASC |
|
|
Total |
|
|
Risk |
|
|
ASC |
|
|
Total |
|
|
Medical: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial |
|
|
5,014 |
|
|
|
9,401 |
|
|
|
14,415 |
|
|
|
4,621 |
|
|
|
8,737 |
|
|
|
13,358 |
|
Medicare |
|
|
102 |
|
|
|
20(1) |
|
|
|
122 |
|
|
|
99 |
|
|
|
|
|
|
|
99 |
|
Medicaid |
|
|
|
|
|
|
113 |
|
|
|
113 |
|
|
|
|
|
|
|
113 |
|
|
|
113 |
|
|
Total Medical Membership |
|
|
5,116 |
|
|
|
9,534 |
|
|
|
14,650 |
|
|
|
4,720 |
|
|
|
8,850 |
|
|
|
13,570 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dental
(2) |
|
|
5,038 |
|
|
|
7,993 |
|
|
|
13,031 |
|
|
|
4,674 |
|
|
|
6,996 |
|
|
|
11,670 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pharmacy
(3) |
|
|
|
|
|
|
|
|
|
|
9,337 |
|
|
|
|
|
|
|
|
|
|
|
8,323 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consumer-directed
health plans(4) |
|
|
|
|
|
|
|
|
|
|
433 |
|
|
|
|
|
|
|
|
|
|
|
214 |
|
|
|
|
|
(1) |
|
Medicare ASC members represent those served through our
participation in the Medicare Chronic Care Improvement Program. |
(2) |
|
In 2005, we began including Aetna Global Benefits dental membership.
Previously reported dental membership has been revised accordingly. |
(3) |
|
At September 30, 2005 and 2004, pharmacy members in thousands include 8,791 and 7,896
members, respectively, receiving pharmacy benefit management services and 546 and 427
members, respectively, who purchased medications through our mail order pharmacy. |
(4) |
|
Represents members in consumer-directed health plans included
in our Commercial medical membership. |
Total medical and dental membership as of September 30, 2005 increased by 1.1 million
(including approximately 170,000 Risk members associated with the acquisition of SRC) and 1.4
million members, respectively, compared to September 30, 2004. The percentage of Risk and ASC
medical membership was approximately 35% and 65%, respectively, at both September 30, 2005 and
2004.
GROUP INSURANCE
Group Insurance includes primarily group life insurance products offered on a Risk basis, including
basic term group life insurance, group universal life, supplemental or voluntary programs and
accidental death and dismemberment coverage. Group Insurance also includes disability products
offered on both a Risk and an employer-funded basis, which consist primarily of short-term and
long-term disability insurance (and products which combine both), as well as long-term care
products, which provide benefits offered to cover the cost of care in private home settings, adult
day care, assisted living or nursing facilities.
Page 26
Operating Summary for the Three and Nine Months Ended September 30, 2005 and 2004:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
September 30, |
|
|
September 30, |
(Millions) |
|
2005 |
|
|
2004 |
|
|
2005 |
|
|
2004 |
|
|
Premiums: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life |
|
$ |
322.9 |
|
|
$ |
309.5 |
|
|
$ |
985.1 |
|
|
$ |
900.5 |
|
Disability |
|
|
91.0 |
|
|
|
85.0 |
|
|
|
281.1 |
|
|
|
233.9 |
|
Long-term care |
|
|
24.2 |
|
|
|
21.1 |
|
|
|
70.5 |
|
|
|
61.4 |
|
|
Total premiums |
|
|
438.1 |
|
|
|
415.6 |
|
|
|
1,336.7 |
|
|
|
1,195.8 |
|
|
Administrative services contract fees |
|
|
7.0 |
|
|
|
6.5 |
|
|
|
21.7 |
|
|
|
20.1 |
|
Net investment income |
|
|
78.8 |
|
|
|
63.7 |
|
|
|
216.2 |
|
|
|
201.0 |
|
Other revenue |
|
|
.8 |
|
|
|
.9 |
|
|
|
2.6 |
|
|
|
2.6 |
|
Net realized capital gains |
|
|
5.1 |
|
|
|
5.5 |
|
|
|
10.1 |
|
|
|
21.3 |
|
|
Total revenue |
|
|
529.8 |
|
|
|
492.2 |
|
|
|
1,587.3 |
|
|
|
1,440.8 |
|
|
Current and future benefits |
|
|
418.4 |
|
|
|
388.6 |
|
|
|
1,264.8 |
|
|
|
1,134.1 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling expenses |
|
|
20.6 |
|
|
|
17.0 |
|
|
|
60.5 |
|
|
|
47.5 |
|
General and administrative expenses (1) |
|
|
41.5 |
|
|
|
39.3 |
|
|
|
122.9 |
|
|
|
114.7 |
|
|
Total benefits and expenses |
|
|
480.5 |
|
|
|
444.9 |
|
|
|
1,448.2 |
|
|
|
1,296.3 |
|
|
Income before income taxes |
|
|
49.3 |
|
|
|
47.3 |
|
|
|
139.1 |
|
|
|
144.5 |
|
Income taxes |
|
|
13.5 |
|
|
|
13.2 |
|
|
|
38.0 |
|
|
|
42.2 |
|
|
Net income |
|
$ |
35.8 |
|
|
$ |
34.1 |
|
|
$ |
101.1 |
|
|
$ |
102.3 |
|
|
|
Net realized capital gains, net of tax (included above) |
|
$ |
3.3 |
|
|
$ |
3.6 |
|
|
$ |
6.6 |
|
|
$ |
13.8 |
|
|
|
|
|
(1) |
|
Includes salaries and related benefit expenses of $25.5
million and $77.8 million for the three and nine months
ended September 30, 2005, respectively, and $22.9
million and $66.1 million, respectively, for the
corresponding periods in 2004. |
Group Insurance Results
The table presented below reconciles operating earnings to net income reported in accordance with
GAAP for the three and nine months ended September 30, 2005 and 2004. Operating earnings exclude
realized capital gains and losses. We believe excluding realized capital gains and losses to
arrive at operating earnings provides more useful information as to our underlying business
performance. Realized capital gains and losses arise from various types of transactions primarily
in the course of managing a portfolio of assets that support the payment of liabilities, but these
transactions do not directly relate to the underwriting or servicing of products for customers and
are not directly related to the core performance of our business operations. In addition,
management uses operating earnings to assess performance and make operating decisions.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
September 30, |
|
|
September 30, |
(Millions, after tax) |
|
2005 |
|
|
2004 |
|
|
2005 |
|
|
2004 |
|
|
Net income |
|
$ |
35.8 |
|
|
$ |
34.1 |
|
|
$ |
101.1 |
|
|
$ |
102.3 |
|
Net realized capital gains |
|
|
(3.3 |
) |
|
|
(3.6 |
) |
|
|
(6.6 |
) |
|
|
(13.8 |
) |
|
Operating earnings |
|
$ |
32.5 |
|
|
$ |
30.5 |
|
|
$ |
94.5 |
|
|
$ |
88.5 |
|
|
Operating earnings for the three and nine months ended September 30, 2005 increased
approximately $2 million and $6 million, respectively, compared to the corresponding periods in
2004. Operating earnings for the three and nine months ended September 30, 2005, when compared to the corresponding periods in 2004, reflect
higher premiums from increased membership and higher net investment income (due to higher mortgage
loan prepayment fees, yields from debt securities and limited partnership income), substantially
offset by higher benefits and operating expenses. Operating earnings for the three
months ended September 30, 2005, when compared to the
corresponding period in 2004, reflect lower
underwriting margins. The total underwriting margin for the three months ended September 30, 2005
reflect higher benefit cost ratios in Life and Disability products when compared to the
corresponding period in 2004. The benefit cost ratio was 95.5% and 94.6% for the three and nine
months ended September 30, 2005, respectively, compared to 93.5% and 94.8% for the corresponding
periods in 2004. Operating expenses increased primarily due to higher employee related costs and
selling expenses associated with higher membership.
Page 27
Net realized capital gains for the three months ended September 30, 2005 are due primarily to gains
on debt securities from rebalancing our investment portfolio, recoveries from investments
previously written-down and real estate gains partially offset by losses from futures contracts
used for correlating the maturities of invested assets with the payment of expected liabilities.
Net realized capital gains for the nine months ended September 30, 2005 are due primarily to
recoveries from investments previously written-down, real estate gains and gains on debt securities
from rebalancing our investment portfolio in a low interest rate environment. Net realized capital
gains for the three and nine months ended September 30, 2004 are due primarily to gains on debt
securities from rebalancing our investment portfolio in a low interest rate environment partially
offset by losses from the write-down of other invested assets.
Membership
Group Insurances membership at September 30, 2005 and 2004 was as follows:
|
|
|
|
|
|
|
|
|
(Thousands) |
|
2005 |
|
|
2004 |
|
|
Life |
|
|
10,872 |
|
|
|
10,723 |
|
Disability |
|
|
2,568 |
|
|
|
2,348 |
|
Long-term care |
|
|
235 |
|
|
|
216 |
|
|
Total |
|
|
13,675 |
|
|
|
13,287 |
|
|
Total Group Insurance membership as of September 30, 2005 increased by .4 million members when
compared to September 30, 2004. New membership in Group Insurance was 1.5 million for the twelve
months ended September 30, 2005, and lapses and in-force membership reductions were 1.1 million for
the same period.
LARGE CASE PENSIONS
Large Case Pensions manages a variety of retirement products (including pension and annuity
products) primarily for defined benefit and defined contribution plans. These products provide a
variety of funding and benefit payment distribution options and other services. The Large Case
Pensions segment includes certain discontinued products.
Operating Summary for the Three and Nine Months Ended September 30, 2005 and 2004:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
September 30, |
|
|
September 30, |
(Millions) |
|
2005 |
|
|
2004 |
|
|
2005 |
|
|
2004 |
|
|
Premiums |
|
$ |
56.1 |
|
|
$ |
47.9 |
|
|
$ |
157.7 |
|
|
$ |
144.8 |
|
Net investment income |
|
|
124.2 |
|
|
|
125.9 |
|
|
|
393.3 |
|
|
|
390.7 |
|
Other revenue |
|
|
3.0 |
|
|
|
2.9 |
|
|
|
8.5 |
|
|
|
8.6 |
|
Net realized capital gains |
|
|
1.5 |
|
|
|
3.4 |
|
|
|
.8 |
|
|
|
10.8 |
|
|
Total revenue |
|
|
184.8 |
|
|
|
180.1 |
|
|
|
560.3 |
|
|
|
554.9 |
|
|
Current and future benefits |
|
|
163.4 |
|
|
|
160.0 |
|
|
|
513.6 |
|
|
|
496.5 |
|
General and administrative expenses (1) |
|
|
5.1 |
|
|
|
5.1 |
|
|
|
13.3 |
|
|
|
15.1 |
|
Reduction of reserve for anticipated future losses on discontinued products |
|
|
|
|
|
|
|
|
|
|
(66.7 |
) |
|
|
|
|
|
Total benefits and expenses |
|
|
168.5 |
|
|
|
165.1 |
|
|
|
460.2 |
|
|
|
511.6 |
|
|
Income before income taxes |
|
|
16.3 |
|
|
|
15.0 |
|
|
|
100.1 |
|
|
|
43.3 |
|
Income taxes |
|
|
5.7 |
|
|
|
5.1 |
|
|
|
35.0 |
|
|
|
14.6 |
|
|
Net income |
|
$ |
10.6 |
|
|
$ |
9.9 |
|
|
$ |
65.1 |
|
|
$ |
28.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net realized capital gains, net of tax (included above) |
|
$ |
1.0 |
|
|
$ |
2.2 |
|
|
$ |
.5 |
|
|
$ |
7.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets under management: (2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fully guaranteed discontinued products |
|
|
|
|
|
|
|
|
|
$ |
4,485.7 |
|
|
$ |
4,611.8 |
|
Experience-rated |
|
|
|
|
|
|
|
|
|
|
4,390.9 |
|
|
|
4,555.7 |
|
Non-guaranteed (3) |
|
|
|
|
|
|
|
|
|
|
11,536.4 |
|
|
|
10,071.3 |
|
|
Total assets under management |
|
|
|
|
|
|
|
|
|
$ |
20,413.0 |
|
|
$ |
19,238.8 |
|
|
|
|
|
(1) |
|
Includes salaries and related benefit expenses of $3.7 million and $11.0 million for the three and nine months ended
September 30, 2005, respectively, and $3.6 million and $10.7 million, respectively, for the corresponding periods in
2004. |
(2) |
|
Excludes net unrealized capital gains of $424.6 million and $522.4 million at September 30, 2005 and 2004, respectively. |
(3) |
|
The increase in non-guaranteed assets under management in 2005 is due primarily to investment appreciation and
additional deposits accepted from existing customers. |
Page 28
Large Case Pension Results
The table presented below reconciles operating earnings to net income reported in accordance with
GAAP for the three and nine months ended September 30, 2005 and 2004. Operating earnings exclude
realized capital gains and losses and changes to the reserve for anticipated future losses on
discontinued products. We believe excluding realized capital gains and losses to arrive at
operating earnings provides more useful information as to our underlying business performance.
Realized capital gains and losses arise from various types of transactions primarily in the course
of managing a portfolio of assets that support the payment of liabilities, but these transactions
do not directly relate to the underwriting or servicing of products for customers and are not
directly related to the core performance of our business operations. We believe excluding any
changes to the reserve for anticipated future losses on discontinued products provides more useful
information as to our continuing products and is consistent with the treatment of the results of
operations of these discontinued products, which are credited/charged to the reserve and do not
affect our results of operations. In addition, management uses operating earnings to assess
performance and make operating decisions.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
September 30, |
|
|
September 30, |
(Millions) |
|
2005 |
|
|
2004 |
|
|
2005 |
|
|
2004 |
|
|
Net income |
|
$ |
10.6 |
|
|
$ |
9.9 |
|
|
$ |
65.1 |
|
|
$ |
28.7 |
|
Other items included in net income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net realized capital gains |
|
|
(1.0 |
) |
|
|
(2.2 |
) |
|
|
(.5 |
) |
|
|
(7.0 |
) |
Reduction of the reserve for anticipated future losses on discontinued products |
|
|
|
|
|
|
|
|
|
|
(43.4 |
) |
|
|
|
|
|
Operating earnings |
|
$ |
9.6 |
|
|
$ |
7.7 |
|
|
$ |
21.2 |
|
|
$ |
21.7 |
|
|
The increase in operating earnings for the three months ended September 30, 2005 compared to
the corresponding period in 2004 is primarily due to higher net investment income in continuing
products.
The reduction of the reserve for anticipated future losses on discontinued products for the nine
months ended September 30, 2005 is primarily due to favorable investment performance and favorable
mortality and retirement experience compared to prior assumptions.
General account assets supporting experience-rated products (where the contractholder, not us,
assumes investment and other risks subject to, among other things, certain minimum guarantees) may
be subject to participant or contractholder withdrawal. Experience-rated contractholder and
participant withdrawals for the three and nine months ended September 30, 2005 and 2004 were as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
September 30, |
|
|
September 30, |
(Millions) |
|
2005 |
|
|
2004 |
|
|
2005 |
|
|
2004 |
|
|
Scheduled contract maturities and benefit payments (1) |
|
$ |
88.7 |
|
|
$ |
179.6 |
|
|
$ |
275.8 |
|
|
$ |
605.2 |
|
Contractholder withdrawals other than scheduled contract maturities
and benefit payments |
|
|
27.3 |
|
|
|
16.0 |
|
|
|
42.3 |
|
|
|
73.3 |
|
Participant-directed withdrawals |
|
|
4.9 |
|
|
|
6.5 |
|
|
|
14.0 |
|
|
|
21.3 |
|
|
|
|
|
(1) |
|
Includes payments made upon contract maturity and other amounts distributed in accordance with contract schedules. |
Discontinued Products
We discontinued the sale of our fully guaranteed large case pension products (single-premium
annuities (SPAs) and guaranteed investment contracts (GICs)) in 1993. We established a reserve
for anticipated future losses on these products based on the present value of the difference
between the expected cash flows from the assets supporting these products and the cash flows
expected to be required to meet the product obligations.
Results of operations of discontinued products, including net realized capital gains (losses), are
credited (charged) to the reserve for anticipated future losses. Our results of operations would
be adversely affected to the extent that future losses on the products are greater than anticipated
and favorably affected to the extent future losses are less than anticipated.
The factors contributing to changes in the reserve for anticipated future losses are: operating
income or loss, realized capital gains or losses and mortality gains or losses. Operating income
or loss is equal to revenue less expenses. Realized capital gains or losses reflect the excess
(deficit) of sales price over (below) the carrying value of assets sold and any
other-than-temporary impairments. Mortality gains or losses reflect the mortality and
retirement experience related to SPAs. A mortality gain (loss) occurs when an annuitant or a
beneficiary dies sooner (later) than expected. A retirement gain (loss) occurs when an annuitant
retires later (earlier) than expected.
Page 29
The results of discontinued products for the three and nine months ended September 30, 2005 and
2004 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
September 30, |
|
|
September 30, |
(Millions) |
|
2005 |
|
|
2004 |
|
|
2005 |
|
|
2004 |
|
|
Interest deficit (1) |
|
$ |
(8.4 |
) |
|
$ |
(8.6 |
) |
|
$ |
(6.6 |
) |
|
$ |
(21.2 |
) |
Net realized capital gains |
|
|
8.0 |
|
|
|
4.3 |
|
|
|
8.0 |
|
|
|
13.6 |
|
Interest earned on receivable from continuing products |
|
|
4.8 |
|
|
|
4.9 |
|
|
|
15.0 |
|
|
|
14.6 |
|
Other, net |
|
|
1.7 |
|
|
|
2.6 |
|
|
|
9.8 |
|
|
|
9.7 |
|
|
Results of discontinued products, after tax |
|
$ |
6.1 |
|
|
$ |
3.2 |
|
|
$ |
26.2 |
|
|
$ |
16.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Results of discontinued products, pretax |
|
$ |
7.2 |
|
|
$ |
3.5 |
|
|
$ |
33.3 |
|
|
$ |
21.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net realized capital gains from bonds, after tax (included above) |
|
$ |
5.3 |
|
|
$ |
2.2 |
|
|
$ |
5.2 |
|
|
$ |
8.6 |
|
|
|
|
|
(1) |
|
The interest deficit is the difference between earnings on invested assets and interest credited to contractholders. |
The interest deficit for the nine months ended September 30, 2005 decreased compared to the
corresponding period in 2004 primarily due to higher private equity partnership income.
For the three and nine months ended September 30, 2005, net realized capital gains are due
primarily to gains from the sale of debt and equity securities partially offset by losses on
futures contracts. For the three months ended September 30, 2004, net realized capital gains are
due primarily to the sale of debt securities in a low interest rate environment and gains from
futures contracts. For the nine months ended September 30, 2004, net realized capital gains are
due primarily to gains from the sale of debt securities in a low interest rate environment and
mortgage loan equity participations as well as gains from futures contracts.
At the time of discontinuance, a receivable from Large Case Pensions continuing products
equivalent to the net present value of the anticipated cash flow shortfalls was established for the
discontinued products. Interest on the receivable is accrued at the discount rate that was used to
calculate the reserve. Total assets supporting discontinued products and the reserve include a
receivable from continuing products of $367 million at September 30, 2005 and $395 million at
December 31, 2004, net of related deferred taxes payable. These amounts were eliminated in
consolidation.
The reserve for anticipated future losses on discontinued products represents the present value (at
a risk-free rate of return at the time of discontinuance, consistent with the duration of the
liabilities) of the difference between the expected cash flows from the assets supporting
discontinued products and the cash flows expected to be required to meet the obligations of the
outstanding contracts. Calculation of the reserve for anticipated future losses requires
projection of both the amount and the timing of cash flows over approximately the next 30 years,
including consideration of, among other things, future investment results, participant withdrawal
and mortality rates, as well as the cost of asset management and customer service. Since 1993,
there have been no significant changes to the assumptions underlying the calculation of the reserve
related to the projection of the amount and timing of cash flows.
The projection of future investment results considers assumptions for interest rates, bond discount
rates and performance of mortgage loans and real estate. Mortgage loan cash flow assumptions
represent managements best estimate of current and future levels of rent growth, vacancy and
expenses based upon market conditions at each reporting date. The performance of real estate
assets has been consistently estimated using the most recent forecasts available. Since 1997, a
bond default assumption has been included to reflect historical default experience, since the bond
portfolio increased as a percentage of the overall investment portfolio and reflected more bond
credit risk, concurrent with the declines in the commercial mortgage loan and real estate
portfolios.
The previous years actual participant withdrawal experience is used for the current-year
assumption. Prior to 1995, we used the 1983 Group Annuitant Mortality table published by the
Society of Actuaries (the Society). In 1995, the Society published the 1994 Uninsured
Pensioners Mortality table, which we have used since then.
Page 30
Our assumptions about the cost of asset management and customer service reflect actual investment
and general expenses allocated over invested assets.
The activity in the reserve for anticipated future losses on discontinued products for the nine
months ended September 30, 2005 was as follows (pretax):
|
|
|
|
|
(Millions) |
|
|
|
|
|
Reserve for anticipated future losses on discontinued products at December 31, 2004 |
|
$ |
1,079.8 |
|
Operating income |
|
|
13.6 |
|
Net realized capital gains |
|
|
12.2 |
|
Mortality and other |
|
|
7.5 |
|
Reserve reduction |
|
|
(66.7 |
) |
|
Reserve for anticipated future losses on discontinued products at September 30, 2005 |
|
$ |
1,046.4 |
|
|
Management reviews the adequacy of the discontinued products reserve quarterly and, as a
result, $67 million ($43 million after tax) of the reserve
was released in the nine months ended September 30, 2005, primarily due to favorable investment performance and favorable mortality and retirement
experience compared to prior assumptions. The current reserve reflects managements best estimate
of anticipated future losses.
The discontinued products investment portfolio at September 30, 2005 and December 31, 2004 was as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2005 |
|
|
December 31, 2004 |
(Millions) |
|
Amount |
|
|
Percent |
|
|
Amount |
|
|
Percent |
|
|
Debt securities available for sale |
|
$ |
3,134.6 |
|
|
|
65.6 |
% |
|
$ |
3,383.6 |
|
|
|
68.3 |
% |
Loaned securities |
|
|
327.9 |
|
|
|
6.9 |
|
|
|
322.8 |
|
|
|
6.5 |
|
|
Total debt securities |
|
|
3,462.5 |
|
|
|
72.5 |
|
|
|
3,706.4 |
|
|
|
74.8 |
|
Mortgage loans |
|
|
607.2 |
|
|
|
12.7 |
|
|
|
560.3 |
|
|
|
11.3 |
|
Investment real estate |
|
|
110.2 |
|
|
|
2.3 |
|
|
|
114.8 |
|
|
|
2.3 |
|
Equity securities available for sale |
|
|
52.9 |
|
|
|
1.1 |
|
|
|
57.2 |
|
|
|
1.2 |
|
Other (1) |
|
|
545.9 |
|
|
|
11.4 |
|
|
|
514.4 |
|
|
|
10.4 |
|
|
Total |
|
$ |
4,778.7 |
|
|
|
100.0 |
% |
|
$ |
4,953.1 |
|
|
|
100.0 |
% |
|
|
|
|
(1) |
|
Amount includes restricted debt securities on deposit as required by regulatory authorities of $21.3 million at
September 30, 2005 and $20.9 million at December 31, 2004, included in long-term investments on the Consolidated Balance Sheets. |
Distributions on discontinued products for the three and nine months ended September 30, 2005
and 2004 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 30, |
|
|
September 30, |
|
(Millions) |
|
2005 |
|
|
2004 |
|
|
2005 |
|
|
2004 |
|
|
Scheduled contract maturities, settlements and benefit payments |
|
$ |
121.7 |
|
|
$ |
125.6 |
|
|
$ |
368.8 |
|
|
$ |
387.5 |
|
Participant-directed withdrawals |
|
|
|
|
|
|
.1 |
|
|
|
.1 |
|
|
|
.2 |
|
|
Cash required to fund these distributions was provided by earnings and scheduled payments on,
and sales of, invested assets.
CORPORATE INTEREST
Corporate interest expense represents interest incurred on our long-term and short-term debt and is
not recorded in our business segments. After tax interest expense was $21 million and $59 million
for the three and nine months ended September 30, 2005, respectively, compared to $17 million and
$50 million, respectively, for the corresponding periods in 2004. The increase in interest expense
for the three months ended September 30, 2005, when compared to the corresponding period in 2004,
was due to the sale of the interest rate swap agreements discussed below. The increase in interest
expense for the nine months ended September 30, 2005, when compared to the corresponding period in
2004 was related to higher interest rates and the sale of the interest rate swap agreements discussed
below.
In December 2002, we entered into an interest rate swap agreement to convert the fixed rate of 8.5%
on $200 million of our senior notes to a variable rate of three-month LIBOR plus 254.0 basis
points. In December 2001, we entered into an interest rate swap agreement to convert the fixed rate of 8.5% on $350 million
of our senior notes to a variable rate of three-month LIBOR plus 159.5 basis points. Based on the
terms of the swap agreements, they qualified as fair value hedges. In May 2005, we sold both of
these interest rate swap agreements. At the time of the sale of the interest rate swap agreements,
the cumulative fair value adjustment of the debt on the balance sheet was a gain of $7.8 million.
As a result of the sale, the cumulative fair value adjustment will be amortized as a reduction of
interest expense over the remaining life of the applicable senior notes. Additionally, interest
expense will no longer reflect the benefit of these interest rate swap agreements.
Page 31
INVESTMENTS
Investments disclosed in this section relate to our total investment portfolio (including assets
supporting discontinued products and experience-rated products).
Total investments at September 30, 2005 and December 31, 2004 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2005 |
|
|
December 31, 2004 |
|
(Millions) |
|
Current |
|
|
Long-term |
|
|
Total |
|
|
Current |
|
|
Long-term |
|
|
Total |
|
|
Debt securities available for sale: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Available for use in current operations |
|
$ |
13,217.8 |
|
|
$ |
|
|
|
$ |
13,217.8 |
|
|
$ |
14,013.6 |
|
|
$ |
|
|
|
$ |
14,013.6 |
|
Loaned securities |
|
|
1,248.9 |
|
|
|
|
|
|
|
1,248.9 |
|
|
|
1,150.1 |
|
|
|
|
|
|
|
1,150.1 |
|
On deposit, as required by regulatory
authorities |
|
|
|
|
|
|
525.8 |
|
|
|
525.8 |
|
|
|
|
|
|
|
553.4 |
|
|
|
553.4 |
|
|
Debt securities available for sale |
|
|
14,466.7 |
|
|
|
525.8 |
|
|
|
14,992.5 |
|
|
|
15,163.7 |
|
|
|
553.4 |
|
|
|
15,717.1 |
|
Equity securities available for sale |
|
|
33.2 |
|
|
|
36.0 |
|
|
|
69.2 |
|
|
|
34.5 |
|
|
|
40.2 |
|
|
|
74.7 |
|
Short-term investments |
|
|
105.2 |
|
|
|
|
|
|
|
105.2 |
|
|
|
194.5 |
|
|
|
|
|
|
|
194.5 |
|
Mortgage loans |
|
|
36.0 |
|
|
|
1,493.8 |
|
|
|
1,529.8 |
|
|
|
52.7 |
|
|
|
1,348.2 |
|
|
|
1,400.9 |
|
Investment real estate |
|
|
|
|
|
|
226.4 |
|
|
|
226.4 |
|
|
|
|
|
|
|
274.8 |
|
|
|
274.8 |
|
Other investments |
|
|
22.4 |
|
|
|
1,201.8 |
|
|
|
1,224.2 |
|
|
|
5.0 |
|
|
|
1,124.5 |
|
|
|
1,129.5 |
|
|
Total investments |
|
$ |
14,663.5 |
|
|
$ |
3,483.8 |
|
|
$ |
18,147.3 |
|
|
$ |
15,450.4 |
|
|
$ |
3,341.1 |
|
|
$ |
18,791.5 |
|
|
Debt and Equity Securities
Debt securities represented 83% at September 30, 2005 and 84% at December 31, 2004 of our total
general account invested assets and supported the following types of products:
|
|
|
|
|
|
|
|
|
|
|
September 30, |
|
|
December 31, |
|
(Millions) |
|
2005 |
|
|
2004 |
|
|
Supporting discontinued products |
|
$ |
3,483.8 |
|
|
$ |
3,727.3 |
|
Supporting experience-rated products |
|
|
1,958.5 |
|
|
|
2,083.9 |
|
Supporting remaining products |
|
|
9,550.2 |
|
|
|
9,905.9 |
|
|
Total debt securities (1) |
|
$ |
14,992.5 |
|
|
$ |
15,717.1 |
|
|
|
|
|
(1) |
|
Total debt securities include below investment grade securities of $1.0 billion at September 30,
2005, and $927 million at December 31, 2004, of which 30% at
September 30, 2005 and 28% at December 31, 2004 supported
discontinued and experience-rated products. |
Debt securities reflect net unrealized capital gains of $608 million (comprised of gross
unrealized capital gains of $716 million and gross unrealized capital losses of $108 million) at
September 30, 2005 compared with net unrealized capital gains of $910 million (comprised of gross
unrealized capital gains of $949 million and gross unrealized capital losses of $39 million) at
December 31, 2004. Of the net unrealized capital gains at September 30, 2005, $293 million relate
to assets supporting discontinued products and $120 million relate to experience-rated
products. Of the net unrealized capital gains at December 31, 2004, $369 million relate to assets
supporting discontinued products and $177 million relate to experience-rated products.
Equity securities reflect unrealized capital gains of $15 million at September 30, 2005 compared
with unrealized capital gains of $13 million at December 31, 2004.
If management believes a decline in the value of a particular investment is temporary, the decline
is recorded as an unrealized loss in Shareholders Equity, and if the decline is
other-than-temporary, the carrying value of the investment is written down and a realized capital
loss is recorded in the Consolidated Statement of Income consistent with the guidance of FAS No. 115, Accounting for Certain Investments in Debt and Equity
Securities. Our impairment analysis is discussed in more detail in MD&A INVESTMENTS in our
2004 Annual Report.
Page 32
At September 30, 2005 and December 31, 2004, we had no individually material unrealized losses on
debt or equity securities which could have a material impact on our results of operations.
Net Realized Capital Gains and Losses
For the three months ended September 30, 2005, net realized capital gains were $9 million ($6
million after tax) and included recoveries from investments previously written-down of $4 million
($3 million after tax) primarily related to asset backed securities. For the nine months ended
September 30, 2005, net realized capital gains were $19 million ($12 million after tax) and
included recoveries from investments previously written-down of $3 million ($2 million after tax)
primarily related to asset backed securities partially offset by investment write-downs related to
investments in the automotive industry. For the three and nine months ended September 30, 2004,
net realized capital gains were $20 million ($13 million after tax) and $52 million ($34 million
after tax), respectively, and included net investment write-downs from other-than-temporary
impairments of $2 million ($1 million after tax) and $4 million ($3 million after tax),
respectively, primarily related to other invested assets. The factors contributing to the
impairment losses recognized during the nine months ended September 30, 2005 as well as the three
and nine months ended September 30, 2004 did not impact other material investments held at the
time. We had no individually material realized losses on debt or equity securities that impacted
our results of operations during the three and nine months ended September 30, 2005 or 2004.
Mortgage Loans
Our mortgage loan investments, net of impairment reserves, supported the following types of
products at September 30, 2005 and December 31, 2004:
|
|
|
|
|
|
|
|
|
|
|
September 30, |
|
|
December 31, |
|
(Millions) |
|
2005 |
|
|
2004 |
|
|
Supporting discontinued products |
|
$ |
607.2 |
|
|
$ |
560.3 |
|
Supporting experience-rated products |
|
|
312.8 |
|
|
|
305.3 |
|
Supporting remaining products |
|
|
609.8 |
|
|
|
535.3 |
|
|
Total mortgage loans |
|
$ |
1,529.8 |
|
|
$ |
1,400.9 |
|
|
The mortgage loan portfolio balance represented 8% of our total invested assets at September
30, 2005 and 7% at December 31, 2004. Problem, restructured and potential problem loans included
in mortgage loans were $20 million at September 30, 2005 and December 31, 2004, of which 6%
supported discontinued and experience-rated products. Specific impairment reserves on these loans
were $4 million at September 30, 2005 and December 31, 2004.
Risk Management and Market-Sensitive Instruments
We manage interest rate risk by seeking to maintain a tight match between the durations of our
assets and liabilities where appropriate, while credit risk is managed by seeking to maintain high
average quality ratings and diversified sector exposure within the debt securities portfolio. In
connection with our investment and risk management objectives, we also use financial instruments
whose market value is at least partially determined by, among other things, levels of or changes in
interest rates (short-term or long-term), duration, prepayment rates, equity markets or credit
ratings/spreads. Our use of these derivatives is generally limited to hedging purposes and has
principally consisted of using interest rate swap agreements, warrants, forward contracts and
futures contracts. These instruments, viewed separately, subject us to varying degrees of interest
rate, equity price and credit risk. However, when used for hedging, we expect that these
instruments will reduce overall risk.
We regularly evaluate the risk of market-sensitive instruments by examining, among other things,
levels of or changes in interest rates (short-term or long-term), duration, prepayment rates,
equity markets or credit ratings/spreads. We also regularly evaluate the appropriateness of
investments relative to our management-approved investment guidelines (and operate within those
guidelines) and the business objective of the portfolios.
The risks associated with investments supporting experience-rated pension and annuity products in
the Large Case Pensions business are assumed by those contractholders and not by us (subject to,
among other things, certain minimum guarantees). Anticipated future losses associated with
investments supporting discontinued fully guaranteed large case pension products are provided for in the reserve for anticipated future
losses (refer to LARGE CASE PENSIONS Discontinued Products).
Page 33
Management also reviews, on a quarterly basis, the impact of hypothetical net losses in our
consolidated near-term financial position, results of operations and cash flows assuming certain
reasonably possible changes in market rates and prices were to occur. Based on our overall
exposure to interest rate risk and equity price risk, we believe that these changes in market rates
and prices would not materially affect our consolidated near-term financial position, results of
operations or cash flows as of September 30, 2005. Refer to our 2004 Annual Report for a more
complete discussion of Risk Management and Market-Sensitive Instruments.
LIQUIDITY AND CAPITAL RESOURCES
Cash Flows
Generally, we meet our operating requirements by maintaining appropriate levels of liquidity in our
investment portfolio and using overall cash flows from premiums, deposits and income received on
investments. We monitor the duration of our debt securities portfolio (which is highly marketable)
and mortgage loans, and execute purchases and sales of these investments with the objective of
having adequate funds available to satisfy our maturing liabilities. Overall cash flows are used
primarily for claim and benefit payments, contract withdrawals and operating expenses.
The following table for the nine months ended September 30, 2005 breaks out the operating cash
flows of Health Care and Group Insurance and Large Case Pensions separately, as changes in Large
Case Pensions insurance reserves are funded from the sale of investments, which impact cash flows
from investing activities (and not operating cash flows). Refer to the Consolidated Statements of
Cash Flows for additional information.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Health Care |
|
|
Large |
|
|
|
|
|
|
and Group |
|
|
Case |
|
|
|
|
(Millions) |
|
Insurance (1) |
|
|
Pensions |
|
|
Total |
|
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
1,146.4 |
|
|
$ |
65.1 |
|
|
$ |
1,211.5 |
|
Adjustments to reconcile net income to net cash provided by (used for)
operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of other acquired intangible assets |
|
|
38.1 |
|
|
|
|
|
|
|
38.1 |
|
Depreciation and other amortization |
|
|
109.4 |
|
|
|
|
|
|
|
109.4 |
|
Amortization (accretion) of net investment premium (discount) |
|
|
25.6 |
|
|
|
(6.1 |
) |
|
|
19.5 |
|
Net realized capital gains |
|
|
(17.8 |
) |
|
|
(.8 |
) |
|
|
(18.6 |
) |
Changes in assets and liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
Decrease in accrued investment income |
|
|
5.2 |
|
|
|
6.8 |
|
|
|
12.0 |
|
(Increase) decrease in premiums due and other receivables |
|
|
(113.1 |
) |
|
|
6.4 |
|
|
|
(106.7 |
) |
Net change in income taxes |
|
|
441.0 |
|
|
|
16.4 |
|
|
|
457.4 |
|
Net change in other assets and other liabilities |
|
|
(385.2 |
) |
|
|
2.1 |
|
|
|
(383.1 |
) |
Net increase (decrease) in health care and insurance liabilities |
|
|
176.9 |
|
|
|
(237.3 |
) |
|
|
(60.4 |
) |
Other, net |
|
|
(5.5 |
) |
|
|
(26.9 |
) |
|
|
(32.4 |
) |
|
Net cash provided by (used for) operating activities |
|
$ |
1,421.0 |
|
|
$ |
(174.3 |
) |
|
$ |
1,246.7 |
|
|
|
|
|
(1) |
|
Includes corporate interest. |
Cash flows provided by operating activities were approximately $1.2 billion for the nine
months ended September 30, 2005. Cash flows provided by operating activities for Health Care and
Group Insurance were approximately $1.4 billion. Included in this amount were payments of
approximately $150 million pretax related to a prior year physician class action settlement and
$245 million pretax in voluntary pension contributions.
Dividends
On September 29, 2005, our Board declared an annual cash dividend of $.04 per common share to
shareholders of record on the close of business on November 16, 2005. The dividend will be paid on
November 30, 2005. Our Board reviews our common stock dividend annually. Among the factors
considered by the Board in determining the amount of each dividend are our results of operations
and the capital requirements, growth and other characteristics of our businesses.
Page 34
Financings, Financing Capacity and Capitalization
At September 30, 2005, our borrowings were $1.6 billion, consisting entirely of senior notes due in
2006, 2011 and 2041. The current portion of our debt consists of $450 million of 7.375% senior
notes due in March 2006 and is reflected as the current portion of long-term debt in our
consolidated balance sheet. Our 8.5% senior notes due in 2041 are callable beginning in June 2006.
We use short-term borrowings from time to time to address timing differences between cash receipts
and disbursements. There were no short-term borrowings outstanding during the nine months ended
September 30, 2005. Our committed short-term borrowing capacity consists of an $800 million credit
facility which terminates in 2009. The credit facility also provides for the issuance of letters
of credit at our request, of up to $150 million, which count as usage of the available commitments
under the facility. The credit facility permits the aggregate commitments under the facility to be
expanded to a maximum of $1 billion upon our agreement with one or more financial institutions.
Our total debt to capital ratio (total debt divided by shareholders equity plus total debt)
was 14.7% at September 30, 2005. Refer to Note 10 of
Condensed Notes to Consolidated Financial Statements for additional information.
During the three months ended September 30, 2005, we entered into two forward starting swaps in
order to hedge the anticipated change in cash flows associated with interest payments generated by
forecasted future issuance of long-term debt (expected to be issued between September 30, 2005 and
December 31, 2006). Refer to Note 10 of Condensed Notes to Consolidated Financial Statements for
additional information.
Common Stock Transactions
On February 9, 2005, the Board declared a two-for-one stock split of our common stock, which was
effected in the form of a 100% common stock dividend. All shareholders of record at the close
of business on February 25, 2005 (Shareholders of Record) received one additional share of
common stock for each share held on that date. The additional shares of common stock were
distributed to Shareholders of Record in the form of a stock dividend on March 11, 2005. All
share and per share amounts in this MD&A and the accompanying consolidated financial statements
and related notes have been adjusted to reflect the stock split for all periods. In connection
with the stock split, our Board approved an Amendment to our Articles of Incorporation. This
amendment increased the number of our authorized common shares to 1,459,384,998 shares on March
11, 2005 (which has subsequently been reduced due to our share repurchase activity).
On February 11, 2005, the Boards Committee on Compensation and Organization (the Compensation
Committee) granted approximately 4.0 million stock options to employees to purchase our common
shares at $66.75 per share. The February 11, 2005 grants will become 100% vested three years from
the grant date, with one-third of the options vesting on June 30, 2005 and the remaining options
vesting on the second and third anniversaries of the grant date. During the nine months ended
September 30, 2005, we issued approximately 9.3 million common shares for benefit plans,
predominately related to stock option exercises.
Under our share repurchase programs, approximately 16.3 million shares were repurchased during the
nine months ended September 30, 2005. As of September 30, 2005, the capacity remaining under our
share repurchase authorizations was approximately $1.0 billion. Refer to Note 11 of Condensed
Notes to Consolidated Financial Statements for more information. For the third quarter of 2005, we
had weighted average common shares outstanding, including common share equivalents, of
approximately 301 million (refer to Note 4 of Condensed Notes to Consolidated Financial
Statements).
Ratings
As of October 27, 2005 the ratings of Aetna Inc. and Aetna Life Insurance Company (ALIC) were
as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Moody's |
|
|
|
|
|
|
|
|
Investors |
|
Standard |
|
|
A.M. Best |
|
Fitch |
|
Service |
|
& Poor's |
|
|
|
Aetna Inc. (senior debt) (1) |
|
bbb+ |
|
BBB+ |
|
Baa1 |
|
BBB+ |
|
|
|
|
|
|
|
|
|
Aetna Inc. (commercial paper) (1) |
|
AMB-2 |
|
F2 |
|
P-2 |
|
A-2 |
|
|
|
|
|
|
|
|
|
ALIC (financial strength) (1) |
|
A |
|
A+ |
|
A1 |
|
A |
|
|
|
(1) |
|
A.M. Best has the ratings on outlook-stable. Fitch has the
Aetna Inc. senior debt and ALIC ratings on outlook-positive.
Moodys has the ratings on outlook-positive. Standard &
Poors has the Aetna Inc. senior debt and ALIC ratings on
outlook-positive. |
Page 35
CRITICAL ACCOUNTING POLICIES
Refer to Critical Accounting Policies in our 2004 Annual Report for information on accounting
policies that we consider critical in preparing our Consolidated Financial Statements. These
policies include significant estimates made by management using information available at the time
the estimates are made. However, these estimates could change materially if different information
or assumptions were used.
NEW ACCOUNTING STANDARDS
Refer to Note 2 of Condensed Notes to Consolidated Financial Statements for a discussion of
recently issued accounting standards.
REGULATORY ENVIRONMENT
Refer to Regulatory Environment in our 2004 Annual Report for information on regulation of our
business.
FORWARD-LOOKING INFORMATION/RISK FACTORS
The Forward-Looking Information/Risk Factors portion of our 2004 Annual Report contains a
discussion of important risk factors related to our business.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Refer to the information contained in MD&A INVESTMENTS.
Item 4. Controls and Procedures
Disclosure Controls and Procedures
Aetna Inc. and its subsidiaries (collectively, the Company) maintain disclosure controls and
procedures, which are designed to ensure that information required to be disclosed by the Company
in the reports it files or submits under the Securities Exchange Act of 1934, as amended (the
Exchange Act), is recorded, processed, summarized and reported within the time periods specified
in the SECs rules and forms, and that such information is accumulated and communicated to the
Companys management, including its Chief Executive Officer and Chief Financial Officer, as
appropriate to allow timely decisions regarding required disclosure.
An evaluation of the effectiveness of the Companys disclosure controls and procedures as of
September 30, 2005 was conducted under the supervision and with the participation of the
Companys Chief Executive Officer and Chief Financial Officer. Based on that evaluation, the
Companys Chief Executive Officer and Chief Financial Officer have concluded that the Companys
disclosure controls and procedures were adequate and designed to ensure that material information
relating to Aetna Inc. and its consolidated subsidiaries would be made known to the Chief
Executive Officer and Chief Financial Officer by others within those entities, particularly
during the periods when periodic reports under the Exchange Act are being prepared. Refer to the
Certifications by the Companys Chief Executive Officer and Chief Financial Officer filed as
Exhibits 31.1 and 31.2 to this report.
Changes in Internal Control over Financial Reporting
There has been no change in the Companys internal control over financial reporting, identified in
connection with the evaluation of such control, that occurred during the Companys most recent
fiscal quarter that has materially affected, or is reasonably likely to materially affect, the
Companys internal control over financial reporting.
Page 36
PART II OTHER INFORMATION
Item 1. Legal Proceedings
Managed Care Class Action Litigation
From 1999 through early 2003, the Company was involved in purported class action lawsuits as part
of a wave of similar actions targeting the health care payor industry and, in particular, the
conduct of business by managed care companies. These cases, brought on behalf of health care
providers (the Provider Cases), alleged generally that the Company and other defendant managed
care organizations engaged in coercive behavior or a variety of improper business practices in
dealing with health care providers and conspired with one another regarding this purported
wrongful conduct.
Effective May 21, 2003, the Company and representatives of over 900,000 physicians, state and
other medical societies entered into an agreement (the Physician Settlement Agreement) settling
the lead physician Provider Case, which was pending in the United States District Court for the
Southern District of Florida (the Florida Federal Court). The Company believes that the
Physician Settlement Agreement, which has received final court approval, resolves all pending
Provider Cases filed on behalf of physicians that did not opt out of the settlement. During the
second quarter of 2003, the Company recorded a charge of $75 million ($115 million pretax)
(included in other operating expenses) in connection with the Physician Settlement Agreement, net
of an estimated insurance recoverable of $72 million pretax. The Company has not received any
insurance recoveries as of September 30, 2005.
Several Provider Cases filed in 2003 on behalf of purported classes of chiropractors and/or all
non-physician health care providers also make factual and legal allegations similar to those
contained in the other Provider Cases, including allegations of violations of the Racketeer
Influenced and Corrupt Organizations Act. These Provider Cases have been transferred to the
Florida Federal Court for consolidated pretrial proceedings. The Company intends to defend each
of these cases vigorously.
Securities Class Action Litigation
Laborers Tri-County Pension Fund, Goldplate Investment Partners Ltd. and Sheila Shafran filed a
consolidated and amended purported class action complaint (the Securities Complaint) on June 7,
2002 in the United States District Court for the Southern District of New York (the New York
Federal Court). The Securities Complaint supplanted several complaints, filed beginning November
6, 2001, which were voluntarily dismissed or consolidated. Plaintiffs contended that the Company
and two of its current or former officers and directors, William H. Donaldson and John W. Rowe,
M.D., violated federal securities laws. Plaintiffs alleged misrepresentations and omissions
regarding, among other things, the Companys ability to manage and control medical costs and the
appropriate reserve for medical costs as of December 31, 2000, for which they sought unspecified
damages, among other remedies.
Effective February 2005, the parties agreed to dismiss Mr. Donaldson and Dr. Rowe from the action,
and the Company and class representatives entered into an agreement (the Securities Settlement
Agreement) to settle the Securities Complaint. The New York Federal Court approved the
Securities Settlement Agreement on September 12, 2005. The settlement amount was not material to
the Company.
Insurance Industry Brokerage Practices Matters
The Company has received subpoenas and other requests for information from the New York Attorney
General, the Connecticut Attorney General, other attorneys general and various insurance
regulators with respect to an industry wide investigation into certain insurance brokerage
practices, including broker compensation arrangements, bid quoting practices and potential
antitrust violations. The Company may receive additional subpoenas and requests for information
from these attorneys general and regulators. The Company is cooperating with these inquiries.
In connection with this industry wide review, the Company may receive additional subpoenas and
requests for information from other attorneys general and other regulators, and the Company could
be named in related litigation.
Page 37
Other Litigation and Regulatory Proceedings
The Company is involved in numerous other lawsuits arising, for the most part, in the ordinary
course of its business operations, including employment litigation and claims of bad faith,
medical malpractice, non-compliance with state regulatory regimes, marketing misconduct, failure
to timely pay medical claims, investment activities, intellectual property and other litigation in
its Health Care and Group Insurance businesses. Some of these other lawsuits are or are purported
to be class actions. The Company intends to defend these matters vigorously.
In addition, the Companys current and past business practices are subject to review by, and the
Company from time to time receives subpoenas and other requests for information from, various
state insurance and health care regulatory authorities and other state and federal authorities.
There also continues to be heightened review by regulatory authorities of the managed health care
industrys business practices, including utilization management, delegated arrangements and claim
payment practices. As a leading national managed care organization, the Company regularly is the
subject of such reviews. These reviews may result in changes to or clarifications of the
Companys business practices, and may result in fines, penalties or other sanctions.
The Company is unable to predict at this time the ultimate outcome of the remaining Provider
Cases, the insurance industry brokerage practices investigations or other litigation and
regulatory proceedings, and it is reasonably possible that their outcome could be material to the
Company.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
The following table provides information about the monthly share repurchases by the Company as part
of publicly announced programs for the three months ended September 30, 2005:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuer Purchases Of Equity Securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Number of |
|
|
Approximate Dollar |
|
|
|
|
|
|
|
|
|
|
|
Shares Purchased |
|
|
Value of Shares |
|
|
|
|
|
|
|
|
|
|
|
as Part of Publicly |
|
|
That May Yet Be |
|
|
|
Total Number of |
|
|
Average Price |
|
|
Announced |
|
|
Purchased Under the |
|
(Millions, except per share amounts) |
|
Shares Purchased |
|
|
Paid Per Share |
|
|
Plans or Programs |
|
|
Plans or Programs |
|
|
July 1, 2005 - July 30, 2005 |
|
|
|
|
|
$ |
|
|
|
|
|
|
|
$ |
682.7 |
|
August 1, 2005 - August 31, 2005 |
|
|
3.0 |
|
|
|
77.66 |
|
|
|
3.0 |
|
|
|
451.3 |
|
September 1, 2005 - September 30, 2005 |
|
|
2.3 |
|
|
|
82.19 |
|
|
|
2.3 |
|
|
|
1,011.5 |
|
|
Total |
|
|
5.3 |
|
|
$ |
79.64 |
|
|
|
5.3 |
|
|
|
N/A |
|
|
On September 24, 2004, February 25, 2005 and September 29, 2005, the Company announced that
its Board of Directors authorized three share repurchase programs for the repurchase of up to $750
million of common stock each ($2.25 billion in aggregate). During the third quarter of 2005, the
Company repurchased approximately 5.3 million shares of common stock at a cost of $421 million,
completing the September 24, 2004 authorization and utilizing a portion of the February 25, 2005
authorization. At September 30, 2005, the Company has authorization to repurchase up to
approximately $1.0 billion of common stock remaining under the February 25, 2005 and September 29,
2005 authorizations.
On February 9, 2005, the Companys Board of Directors declared a two-for-one stock split of the
Companys common stock, which was effected in the form of a 100% common stock dividend. All
shareholders of record at the close of business on February 25, 2005 (Shareholders of Record)
received one additional share of common stock for each share held on that date. The additional
shares of common stock were distributed to Shareholders of Record in the form of a stock dividend
on March 11, 2005. All share amounts for periods prior to the stock split have been adjusted to
reflect the stock split. In connection with the stock split, the Companys Board of Directors
approved an amendment to the Companys Articles of Incorporation. This amendment increased the
number of authorized common shares of the Company to 1,459,384,998 shares on March 11, 2005 (which has
subsequently been reduced due to the Companys share repurchase activity).
Page 38
Item 6. Exhibits
Exhibits to this Form 10-Q are as follows:
|
|
|
3
|
|
Articles of Incorporation and By-Laws |
|
|
|
3.1
|
|
Amended and Restated By-Laws of Aetna Inc., incorporated herein by
reference to Exhibit 3.1 to Aetna Inc.s Form 8-K filed on October 4,
2005. |
|
|
|
11
|
|
Statements re: computation of per share earnings |
|
|
|
11.1
|
|
Incorporated herein by reference to Note 4 of Condensed Notes to
Consolidated Financial Statements in this Form 10-Q. |
|
|
|
12
|
|
Statements re: computation of ratios |
|
|
|
12.1
|
|
Computation of ratios. |
|
|
|
15
|
|
Letter re: unaudited interim financial information |
|
|
|
15.1
|
|
Letter from KPMG LLP acknowledging awareness of the use of a report
on unaudited interim financial information, dated October 26, 2005. |
|
|
|
31
|
|
Rule 13a-14(a)/15d-14(a) Certifications |
|
|
|
31.1
|
|
Certification. |
|
|
|
31.2
|
|
Certification. |
|
|
|
32
|
|
Section 1350 Certifications |
|
|
|
32.1
|
|
Certification. |
|
|
|
32.2
|
|
Certification. |
Page 39
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
|
|
|
|
Aetna Inc. |
|
|
|
|
|
|
|
|
|
Registrant |
|
|
|
|
|
Date: October 27, 2005
|
|
By
|
|
/s/ Ronald M. Olejniczak |
|
|
|
|
|
|
|
|
|
Ronald M. Olejniczak |
|
|
|
|
Vice President and Controller |
|
|
|
|
(Chief Accounting Officer) |
Page 40
INDEX TO EXHIBITS
|
|
|
|
|
Exhibit |
|
|
|
Filing |
Number |
|
Description |
|
Method |
|
|
|
|
|
12
|
|
Statements re: computation of ratios |
|
|
|
|
|
|
|
12.1
|
|
Computation of ratios.
|
|
Electronic |
|
|
|
|
|
15
|
|
Letter re: unaudited interim financial information |
|
|
|
|
|
|
|
15.1
|
|
Letter from KPMG LLP acknowledging awareness of the
use of a report on unaudited interim financial
information, dated October 26, 2005.
|
|
Electronic |
|
|
|
|
|
31
|
|
Rule 13a-14(a)/15d-14(a) Certifications |
|
|
|
|
|
|
|
31.1
|
|
Certification.
|
|
Electronic |
|
|
|
|
|
31.2
|
|
Certification.
|
|
Electronic |
|
|
|
|
|
32
|
|
Section 1350 Certifications |
|
|
|
|
|
|
|
32.1
|
|
Certification.
|
|
Electronic |
|
|
|
|
|
32.2
|
|
Certification.
|
|
Electronic |
Page 41